food+or+nutrition+or+nutrients	15229304	920	Fawzi WW	A randomized trial of multivitamin supplements and HIV disease progression and mortality.	The New England journal of medicine	2004	81
food+or+nutrition+or+nutrients	16936557	920	DeJesus E	Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients.	Journal of acquired immune deficiency syndromes	2006	70
food+or+nutrition+or+nutrients	17620755	920	Palombi L	Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.	AIDS	2007	58
food+or+nutrition+or+nutrients	19644748	920	Weiser SD	Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco.	AIDS and behavior	2009	49
food+or+nutrition+or+nutrients	19675463	920	Weiser SD	The association between food insecurity and mortality among HIV-infected individuals on HAART.	Journal of acquired immune deficiency syndromes	2009	63
food+or+nutrition+or+nutrients	22903407	920	Weiser SD	Food insecurity is associated with greater acute care utilization among HIV-infected homeless and marginally housed individuals in San Francisco.	Journal of general internal medicine	2013	29
food+or+nutrition+or+nutrients	23741772	920	-			2010	325
food+or+nutrition+or+nutrients	23939234	920	Weiser SD	Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.	AIDS	2014	31
food+or+nutrition+or+nutrients	25095831	920	Govindasamy D	Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review.	Journal of the International AIDS Society	2014	57
food+or+nutrition+or+nutrients	25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4‚Å∫ T cells.	Science	2015	46
immune+or+immune+system	1361652	920	-	1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.	MMWR. Recommendations and reports 	1992	637
immune+or+immune+system	2564898	920	Tersmette M	Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.	Journal of virology	1989	210
immune+or+immune+system	2665081	920	Schnittman SM	The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.	Science	1989	173
immune+or+immune+system	2823150	920	Doyle C	Interaction between CD4 and class II MHC molecules mediates cell adhesion.	Nature	1987	173
immune+or+immune+system	3095663	920	Lifson JD	Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.	Nature	1986	172
immune+or+immune+system	3107838	920	Stein BS	pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.	Cell	1987	235
immune+or+immune+system	3257102	920	Willey RL	In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.	Journal of virology	1988	319
immune+or+immune+system	3299090	920	Richman DD	The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	195
immune+or+immune+system	6096719	920	Dalgleish AG	The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.	Nature	1984	854
immune+or+immune+system	7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
immune+or+immune+system	7675046	920	Walter EA	Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.	The New England journal of medicine	1995	327
immune+or+immune+system	7738173	920	Roederer M	CD8 naive T cell counts decrease progressively in HIV-infected adults.	The Journal of clinical investigation	1995	130
immune+or+immune+system	8095306	920	Connor RI	Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.	Journal of virology	1993	135
immune+or+immune+system	8187174	920	York IA	A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.	Cell	1994	164
immune+or+immune+system	8232937	920	McArthur JC	Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.	Neurology	1993	127
immune+or+immune+system	8614801	920	Wolinsky SM	Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.	Science	1996	176
immune+or+immune+system	9063413	920	Comans-Bitter WM	Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.	The Journal of pediatrics	1997	111
immune+or+immune+system	9188531	920	Orenstein JM	Macrophages as a source of HIV during opportunistic infections.	Science	1997	152
immune+or+immune+system	9204894	920	Autran B	Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.	Science	1997	294
immune+or+immune+system	9360926	920	Wong JK	Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.	Science	1997	528
immune+or+immune+system	9360927	920	Finzi D	Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.	Science	1997	682
immune+or+immune+system	9371822	920	Chun TW	Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	1997	463
immune+or+immune+system	9420212	920	Matano T	Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.	Journal of virology	1998	185
immune+or+immune+system	9525993	920	Koelle DM	Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.	The Journal of clinical investigation	1998	103
immune+or+immune+system	9702772	920	Rufer N	Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.	Nature biotechnology	1998	106
immune+or+immune+system	9883844	920	Hellerstein M	Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.	Nature medicine	1999	140
immune+or+immune+system	10196297	920	Mascola JR	Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.	Journal of virology	1999	336
immune+or+immune+system	10364556	920	Siegal FP	The nature of the principal type 1 interferon-producing cells in human blood.	Science	1999	466
immune+or+immune+system	10500077	920	Gerlach JT	Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.	Gastroenterology	1999	163
immune+or+immune+system	10607709	920	Hazenberg MD	T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).	Blood	2000	129
immune+or+immune+system	10700238	920	Anderson RP	In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.	Nature medicine	2000	95
immune+or+immune+system	10770911	920	Kaplan JE	Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.	Clinical infectious diseases 	2000	115
immune+or+immune+system	11076879	920	Spiller RC	Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.	Gut	2000	188
immune+or+immune+system	11117912	920	Greub G	Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.	Lancet	2000	151
immune+or+immune+system	11309627	920	McCune JM	The dynamics of CD4+ T-cell depletion in HIV disease.	Nature	2001	151
immune+or+immune+system	11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
immune+or+immune+system	11431351	920	Nakano O	Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.	Cancer research	2001	107
immune+or+immune+system	11483742	920	Janini M	Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.	Journal of virology	2001	88
immune+or+immune+system	11500352	920	Retamales I	Amplification of inflammation in emphysema and its association with latent adenoviral infection.	American journal of respiratory and critical care medicine	2001	91
immune+or+immune+system	11585784	920	Lawn SD	Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.	Clinical microbiology reviews	2001	88
immune+or+immune+system	11672548	920	Eckstein DA	HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.	Immunity	2001	106
immune+or+immune+system	11696593	920	Mohri H	Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.	The Journal of experimental medicine	2001	105
immune+or+immune+system	11711588	920	Betts MR	Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.	Journal of virology	2001	251
immune+or+immune+system	11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
immune+or+immune+system	11752161	920	Zhu T	Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.	Journal of virology	2002	115
immune+or+immune+system	11861835	920	Edwards TG	Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.	Journal of virology	2002	92
immune+or+immune+system	11917238	920	Giorgi JV	Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.	Journal of acquired immune deficiency syndromes	2002	96
immune+or+immune+system	12037148	920	Herold KC	Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.	The New England journal of medicine	2002	270
immune+or+immune+system	12086758	920	Badri M	Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.	Lancet	2002	145
immune+or+immune+system	12131186	920	Ling B	SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.	AIDS	2002	89
immune+or+immune+system	12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
immune+or+immune+system	12393849	920	Schacker TW	Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.	The Journal of clinical investigation	2002	82
immune+or+immune+system	12411292	920	Gamadia LE	Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.	Blood	2003	108
immune+or+immune+system	12524385	920	Douek DC	T cell dynamics in HIV-1 infection.	Annual review of immunology	2003	185
immune+or+immune+system	12552096	920	Chun TW	Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.	Proceedings of the National Academy of Sciences of the United States of America	2003	76
immune+or+immune+system	12562034	920	Ammassari A	Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.	Journal of acquired immune deficiency syndromes	2002	116
immune+or+immune+system	12648460	920	Silvestri G	Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.	Immunity	2003	257
immune+or+immune+system	12721933	920	Hunt PW	T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.	The Journal of infectious diseases	2003	296
immune+or+immune+system	12743287	920	Casimiro DR	Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.	Journal of virology	2003	140
immune+or+immune+system	12805437	920	Hermankova M	Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.	Journal of virology	2003	81
immune+or+immune+system	12960820	920	Hazenberg MD	Persistent immune activation in HIV-1 infection is associated with progression to AIDS.	AIDS	2003	255
immune+or+immune+system	14557216	920	Kaufmann GR	CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.	Archives of internal medicine	2003	85
immune+or+immune+system	14557656	920	Guadalupe M	Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.	Journal of virology	2003	336
immune+or+immune+system	14610491	920	Shearer WT	Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.	The Journal of allergy and clinical immunology	2003	152
immune+or+immune+system	14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
immune+or+immune+system	14715541	920	Lugada ES	Population-based hematologic and immunologic reference values for a healthy Ugandan population.	Clinical and diagnostic laboratory immunology	2004	95
immune+or+immune+system	14722271	920	Brenchley JM	T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.	Journal of virology	2004	161
immune+or+immune+system	14966528	920	Papagno L	Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.	PLoS biology	2004	124
immune+or+immune+system	15034567	920	Reece WH	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.	Nature medicine	2004	86
immune+or+immune+system	15117761	920	Deeks SG	Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.	Blood	2004	289
immune+or+immune+system	15163705	920	Han Y	Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.	Journal of virology	2004	127
immune+or+immune+system	15210746	920	Matano T	Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.	The Journal of experimental medicine	2004	89
immune+or+immune+system	15247437	920	Hazuda DJ	Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.	Science	2004	73
immune+or+immune+system	15280419	920	Kinter AL	CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.	The Journal of experimental medicine	2004	159
immune+or+immune+system	15362047	920	Lauer GM	High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.	Gastroenterology	2004	96
immune+or+immune+system	15376257	920	Ulrichs T	Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung.	The Journal of pathology	2004	82
immune+or+immune+system	15545358	920	Messaoudi I	Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense.	The Journal of experimental medicine	2004	72
immune+or+immune+system	15608532	920	Gebo KA	Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.	Journal of acquired immune deficiency syndromes	2005	118
immune+or+immune+system	15616015	920	Lindley S	Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.	Diabetes	2005	181
immune+or+immune+system	15753209	920	Song Z	Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.	The Journal of experimental medicine	2005	74
immune+or+immune+system	15793563	920	Mattapallil JJ	Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.	Nature	2005	557
immune+or+immune+system	15795239	920	Bunde T	Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.	The Journal of experimental medicine	2005	84
immune+or+immune+system	15827153	920	Nobile C	Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.	Journal of virology	2005	65
immune+or+immune+system	15994817	920	Reynolds MR	CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little.	Journal of virology	2005	75
immune+or+immune+system	16048553	920	Faria AM	Oral tolerance.	Immunological reviews	2005	163
immune+or+immune+system	16081852	920	Sutherland JS	Activation of thymic regeneration in mice and humans following androgen blockade.	Journal of immunology	2005	103
immune+or+immune+system	16093359	920	Pudney J	Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.	Biology of reproduction	2005	105
immune+or+immune+system	16116467	920	Klenerman P	T cells and viral persistence: lessons from diverse infections.	Nature immunology	2005	132
immune+or+immune+system	16147978	920	Sylwester AW	Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.	The Journal of experimental medicine	2005	363
immune+or+immune+system	16186818	920	Frentsch M	Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.	Nature medicine	2005	109
immune+or+immune+system	16227428	920	Thompson PM	Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.	Proceedings of the National Academy of Sciences of the United States of America	2005	117
immune+or+immune+system	16276421	920	Chun TW	HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.	The Journal of clinical investigation	2005	117
immune+or+immune+system	16282341	920	Berger C	Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.	Blood	2006	87
immune+or+immune+system	16284464	920	Lawn SD	Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.	AIDS	2005	172
immune+or+immune+system	16339561	920	Fletcher JM	Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.	Journal of immunology	2005	66
immune+or+immune+system	16364740	920	Yamashita M	Retroviral infection of non-dividing cells: old and new perspectives.	Virology	2006	75
immune+or+immune+system	16421594	920	Hiraoka K	Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.	British journal of cancer	2006	76
immune+or+immune+system	16482171	920	Brenchley JM	HIV disease: fallout from a mucosal catastrophe?	Nature immunology	2006	197
immune+or+immune+system	16540683	920	Fecci PE	Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.	Cancer research	2006	144
immune+or+immune+system	16631548	920	Battegay M	Immunological recovery and antiretroviral therapy in HIV-1 infection.	The Lancet. Infectious diseases	2006	61
immune+or+immune+system	16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
immune+or+immune+system	16652060	920	Brahmbhatt H	Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.	Journal of acquired immune deficiency syndromes	2006	71
immune+or+immune+system	16704732	920	Palmer C	Cell-type specific gene expression profiles of leukocytes in human peripheral blood.	BMC genomics	2006	93
immune+or+immune+system	16735692	920	Mattapallil JJ	Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge.	The Journal of experimental medicine	2006	80
immune+or+immune+system	16753288	920	Picker LJ	Immunopathogenesis of acute AIDS virus infection.	Current opinion in immunology	2006	73
immune+or+immune+system	16763152	920	Letvin NL	Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.	Science	2006	178
immune+or+immune+system	16796719	920	Fudaba Y	Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.	American journal of transplantation 	2006	67
immune+or+immune+system	16860762	920	Mempel TR	Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.	Immunity	2006	160
immune+or+immune+system	16878045	920	Nachega JB	Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.	Journal of acquired immune deficiency syndromes	2006	97
immune+or+immune+system	16878047	920	Palella FJ Jr	Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.	Journal of acquired immune deficiency syndromes	2006	382
immune+or+immune+system	16885778	920	Manosuthi W	Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2006	91
immune+or+immune+system	16917006	920	Biggar RJ	Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.	Blood	2006	81
immune+or+immune+system	16936557	920	DeJesus E	Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients.	Journal of acquired immune deficiency syndromes	2006	70
immune+or+immune+system	17024229	920	Mazmanian SK	The love-hate relationship between bacterial polysaccharides and the host immune system.	Nature reviews. Immunology	2006	68
immune+or+immune+system	17084877	920	Thomas ER	Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.	Virology	2007	71
immune+or+immune+system	17090675	920	Levine BL	Gene transfer in humans using a conditionally replicating lentiviral vector.	Proceedings of the National Academy of Sciences of the United States of America	2006	159
immune+or+immune+system	17205456	920	Moore RD	CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.	Clinical infectious diseases 	2007	108
immune+or+immune+system	17210718	920	Piersma SJ	High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.	Cancer research	2007	70
immune+or+immune+system	17224919	920	Han Y	Experimental approaches to the study of HIV-1 latency.	Nature reviews. Microbiology	2007	91
immune+or+immune+system	17251286	920	Friedrich TC	Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication.	Journal of virology	2007	119
immune+or+immune+system	17255740	920	Lawn SD	Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.	AIDS	2007	112
immune+or+immune+system	17258731	920	von Hahn T	Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.	Gastroenterology	2007	144
immune+or+immune+system	17307815	920	Ip JY	Global analysis of alternative splicing during T-cell activation.	RNA	2007	62
immune+or+immune+system	17409164	920	Gray ES	Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.	Journal of virology	2007	148
immune+or+immune+system	17492591	920	Chun TW	Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.	The Journal of infectious diseases	2007	72
immune+or+immune+system	17565153	920	Biggar RJ	AIDS-related cancer and severity of immunosuppression in persons with AIDS.	Journal of the National Cancer Institute	2007	93
immune+or+immune+system	17570691	920	He B	Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.	Immunity	2007	180
immune+or+immune+system	17621240	920	Lewden C	HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.	Journal of acquired immune deficiency syndromes	2007	89
immune+or+immune+system	17693883	920	Kamya MR	Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2007	87
immune+or+immune+system	17709519	920	Milush JM	Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.	Journal of immunology	2007	65
immune+or+immune+system	17717638	920	Talmadge JE	Inflammatory cell infiltration of tumors: Jekyll or Hyde.	Cancer metastasis reviews	2007	75
immune+or+immune+system	17728240	920	Chen P	Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.	Journal of virology	2007	172
immune+or+immune+system	17894380	920	Bhaskaran K	Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.	Annals of neurology	2008	55
immune+or+immune+system	17913974	920	Venet F	Regulatory T cell populations in sepsis and trauma.	Journal of leukocyte biology	2008	56
immune+or+immune+system	17916442	920	Boasso A	Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.	Clinical immunology	2008	78
immune+or+immune+system	17959677	920	Sankaran S	Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.	Journal of virology	2008	82
immune+or+immune+system	17986574	920	Koch S	Cytomegalovirus infection: a driving force in human T cell immunosenescence.	Annals of the New York Academy of Sciences	2007	62
immune+or+immune+system	18077833	920	Parsons JT	Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial.	Journal of acquired immune deficiency syndromes	2007	85
immune+or+immune+system	18091609	920	Horberg MA	Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.	Journal of acquired immune deficiency syndromes	2008	72
immune+or+immune+system	18171295	920	Hunt PW	Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.	The Journal of infectious diseases	2008	248
immune+or+immune+system	18172269	920	Welters MJ	Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.	Clinical cancer research 	2008	101
immune+or+immune+system	18198941	920	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	154
immune+or+immune+system	18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
immune+or+immune+system	18222733	920	Czesnikiewicz-Guzik M	T cell subset-specific susceptibility to aging.	Clinical immunology	2008	98
immune+or+immune+system	18240953	920	Moir S	Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.	The Journal of infectious diseases	2008	62
immune+or+immune+system	18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
immune+or+immune+system	18375792	920	Stasi R	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.	Blood	2008	58
immune+or+immune+system	18382686	920	Funderburg N	Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.	PloS one	2008	60
immune+or+immune+system	18413766	920	Singh H	Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.	Cancer research	2008	99
immune+or+immune+system	18427202	920	Baker JV	CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.	AIDS	2008	106
immune+or+immune+system	18427206	920	Toure S	Rapid scaling-up of antiretroviral therapy in 10,000 adults in C√¥te d'Ivoire: 2-year outcomes and determinants.	AIDS	2008	101
immune+or+immune+system	18494555	920	Bisson GP	Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.	PLoS medicine	2008	68
immune+or+immune+system	18525257	920	Sagot-Lerolle N	Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.	AIDS	2008	63
immune+or+immune+system	18525258	920	Archin NM	Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.	AIDS	2008	84
immune+or+immune+system	18579608	920	Chase AJ	Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.	Journal of virology	2008	59
immune+or+immune+system	18598193	920	Estes J	Collagen deposition limits immune reconstitution in the gut.	The Journal of infectious diseases	2008	63
immune+or+immune+system	18604266	920	Nielsen M	Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.	PLoS computational biology	2008	83
immune+or+immune+system	18664624	920	Brenchley JM	Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.	Blood	2008	245
immune+or+immune+system	18728188	920	Swijnenburg RJ	Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.	Proceedings of the National Academy of Sciences of the United States of America	2008	92
immune+or+immune+system	18776940	920	Manches O	HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.	The Journal of clinical investigation	2008	93
immune+or+immune+system	18802153	920	Dieu-Nosjean MC	Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.	Journal of clinical oncology 	2008	160
immune+or+immune+system	18989232	920	Moore DM	CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2008	52
immune+or+immune+system	19056990	920	Mold JE	Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.	Science	2008	207
immune+or+immune+system	19079157	920	Brenchley JM	HIV infection and the gastrointestinal immune system.	Mucosal immunology	2008	132
immune+or+immune+system	19079215	920	Macal M	Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.	Mucosal immunology	2008	81
immune+or+immune+system	19105657	920	M√ºnz C	Enhancing immunity through autophagy.	Annual review of immunology	2009	87
immune+or+immune+system	19114870	920	Lawn SD	Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa.	AIDS	2009	71
immune+or+immune+system	19123865	920	Robbins GK	Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.	Clinical infectious diseases 	2009	73
immune+or+immune+system	19123868	920	Gazzola L	The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.	Clinical infectious diseases 	2009	65
immune+or+immune+system	19171897	920	Brandes M	Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
immune+or+immune+system	19174797	920	Cremon C	Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.	The American journal of gastroenterology	2009	69
immune+or+immune+system	19223334	920	Chi BH	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.	International journal of epidemiology	2009	48
immune+or+immune+system	19259065	920	Wang GP	Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.	Molecular therapy 	2009	55
immune+or+immune+system	19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
immune+or+immune+system	19282780	920	Nachega JB	Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.	Journal of acquired immune deficiency syndromes	2009	102
immune+or+immune+system	19383966	920	Hasegawa A	The level of monocyte turnover predicts disease progression in the macaque model of AIDS.	Blood	2009	61
immune+or+immune+system	19390417	920	Hsue PY	Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.	AIDS	2009	123
immune+or+immune+system	19430306	920	Tuboi SH	Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean.	Journal of acquired immune deficiency syndromes	2009	47
immune+or+immune+system	19504725	920	Bassett IV	Loss to care and death before antiretroviral therapy in Durban, South Africa.	Journal of acquired immune deficiency syndromes	2009	90
immune+or+immune+system	19535437	920	Brennan TP	Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.	Journal of virology	2009	62
immune+or+immune+system	19550350	920	Micek MA	Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment.	Journal of acquired immune deficiency syndromes	2009	73
immune+or+immune+system	19564353	920	Geiger R	Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells.	The Journal of experimental medicine	2009	49
immune+or+immune+system	19570871	920	Dinoso JB	A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.	Journal of virology	2009	66
immune+or+immune+system	19571723	920	Marin B	Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.	AIDS	2009	71
immune+or+immune+system	19617846	920	Bedimo RJ	Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.	Journal of acquired immune deficiency syndromes	2009	57
immune+or+immune+system	19640996	920	Piantadosi A	Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.	Journal of virology	2009	80
immune+or+immune+system	19647202	920	Carson KR	Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.	The Lancet. Oncology	2009	110
immune+or+immune+system	19648510	920	Chaturvedi AK	Risk of human papillomavirus-associated cancers among persons with AIDS.	Journal of the National Cancer Institute	2009	128
immune+or+immune+system	19673615	920	Castelnuovo B	Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.	Clinical infectious diseases 	2009	58
immune+or+immune+system	19675463	920	Weiser SD	The association between food insecurity and mortality among HIV-infected individuals on HAART.	Journal of acquired immune deficiency syndromes	2009	63
immune+or+immune+system	19713549	920	Barski A	Chromatin poises miRNA- and protein-coding genes for expression.	Genome research	2009	76
immune+or+immune+system	19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
immune+or+immune+system	19745753	920	Geng EH	Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.	Journal of acquired immune deficiency syndromes	2010	120
immune+or+immune+system	19770514	920	Sauce D	Evidence of premature immune aging in patients thymectomized during early childhood.	The Journal of clinical investigation	2009	65
immune+or+immune+system	19837074	920	Lin J	Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance.	Journal of immunological methods	2010	120
immune+or+immune+system	19838127	920	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	41
immune+or+immune+system	19890183	920	Deeks SG	Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.	Topics in HIV medicine 	2009	88
immune+or+immune+system	20004464	920	DART Trial Team.	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.	Lancet	2010	126
immune+or+immune+system	20035164	920	Brady MT	Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.	Journal of acquired immune deficiency syndromes	2010	93
immune+or+immune+system	20086230	920	Vendrame F	Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.	Diabetes	2010	62
immune+or+immune+system	20108382	920	Lawn SD	Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.	AIDS	2009	81
immune+or+immune+system	20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
immune+or+immune+system	20139992	920	Flatz L	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.	Nature medicine	2010	43
immune+or+immune+system	20201977	920	Yi JS	T-cell exhaustion: characteristics, causes and conversion.	Immunology	2010	90
immune+or+immune+system	20208541	920	Carter CC	HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.	Nature medicine	2010	112
immune+or+immune+system	20234368	920	Daayana S	Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.	British journal of cancer	2010	57
immune+or+immune+system	20237308	920	Robertson KR	Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.	Neurology	2010	50
immune+or+immune+system	20306555	920	Marinda ET	Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2010	43
immune+or+immune+system	20335261	920	Julg B	Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.	Journal of virology	2010	49
immune+or+immune+system	20352098	920	Dheda K	Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.	PloS one	2010	47
immune+or+immune+system	20399961	920	Mougiakakos D	Regulatory T cells in cancer.	Advances in cancer research	2010	88
immune+or+immune+system	20414655	920	Ostrand-Rosenberg S	Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.	Cancer immunology, immunotherapy 	2010	146
immune+or+immune+system	20415573	920	Althoff KN	Late presentation for human immunodeficiency virus care in the United States and Canada.	Clinical infectious diseases 	2010	80
immune+or+immune+system	20428171	920	Baranzini SE	Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.	Nature	2010	122
immune+or+immune+system	20505494	920	Ford ES	Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.	AIDS	2010	73
immune+or+immune+system	20550452	920	Julg B	Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.	Clinical infectious diseases 	2010	49
immune+or+immune+system	20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
immune+or+immune+system	20588185	920	Fenner L	Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.	Journal of acquired immune deficiency syndromes	2010	45
immune+or+immune+system	20610331	920	Lawn SD	Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.	The Lancet. Infectious diseases	2010	56
immune+or+immune+system	20622679	920	Mtapuri-Zinyowera S	Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.	Journal of acquired immune deficiency syndromes	2010	61
immune+or+immune+system	20683336	920	Selke HM	Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya.	Journal of acquired immune deficiency syndromes	2010	69
immune+or+immune+system	20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
immune+or+immune+system	20827216	920	Kranzer K	Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors.	Journal of acquired immune deficiency syndromes	2010	43
immune+or+immune+system	20833654	920	Murphy A	Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes.	Human molecular genetics	2010	57
immune+or+immune+system	20844049	920	Murray SM	Reduction of immune activation with chloroquine therapy during chronic HIV infection.	Journal of virology	2010	48
immune+or+immune+system	20889546	920	Gordon SN	Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.	Journal of immunology	2010	48
immune+or+immune+system	20924117	920	Kennedy EM	Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages.	The Journal of biological chemistry	2010	42
immune+or+immune+system	21034222	920	Moir S	Pathogenic mechanisms of HIV disease.	Annual review of pathology	2011	83
immune+or+immune+system	21048528	920	Issa F	Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.	Transplantation	2010	55
immune+or+immune+system	21098232	920	Draper SJ	Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.	Journal of immunology	2010	49
immune+or+immune+system	21105780	920	Soghoian DZ	Cytolytic CD4(+) T cells in viral immunity.	Expert review of vaccines	2010	48
immune+or+immune+system	21107266	920	Davies MA	Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.	Journal of acquired immune deficiency syndromes	2011	39
immune+or+immune+system	21116186	920	Carrico AW	Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.	Journal of acquired immune deficiency syndromes	2011	37
immune+or+immune+system	21148519	920	Peggs KS	Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.	Clinical infectious diseases 	2011	43
immune+or+immune+system	21174240	920	Heaton RK	HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.	Journal of neurovirology	2011	438
immune+or+immune+system	21188221	920	Jung C	Peyer's Patches: The Immune Sensors of the Intestine.	International journal of inflammation	2010	44
immune+or+immune+system	21211639	920	Akdis CA	Mechanisms of allergen-specific immunotherapy.	The Journal of allergy and clinical immunology	2011	60
immune+or+immune+system	21220772	920	Kaplan RC	T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.	The Journal of infectious diseases	2011	106
immune+or+immune+system	21249232	920	Mikell I	Characteristics of the earliest cross-neutralizing antibody response to HIV-1.	PLoS pathogens	2011	135
immune+or+immune+system	21325137	920	Ganesan A	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.	The Journal of infectious diseases	2011	48
immune+or+immune+system	21367910	920	Anderson JA	Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.	Journal of virology	2011	38
immune+or+immune+system	21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
immune+or+immune+system	21398051	920	Finkelstein SE	Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.	International journal of radiation oncology, biology, physics	2012	35
immune+or+immune+system	21403397	920	Chen H	CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.	The Journal of clinical investigation	2011	69
immune+or+immune+system	21412126	920	Appay V	Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.	AIDS	2011	41
immune+or+immune+system	21436711	920	Ellis CL	Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.	Journal of acquired immune deficiency syndromes	2011	45
immune+or+immune+system	21471231	920	Ciccone EJ	CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.	Journal of virology	2011	35
immune+or+immune+system	21471244	920	Xing S	Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.	Journal of virology	2011	79
immune+or+immune+system	21494598	920	Merlini E	Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.	PloS one	2011	42
immune+or+immune+system	21499132	920	Fadul CE	Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.	Journal of immunotherapy	2011	50
immune+or+immune+system	21502083	920	Hunt PW	Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.	The Journal of infectious diseases	2011	98
immune+or+immune+system	21543722	920	Letvin NL	Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.	Science translational medicine	2011	109
immune+or+immune+system	21559280	920	Boyles TH	Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.	PloS one	2011	38
immune+or+immune+system	21625591	920	Gallegos AM	A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo.	PLoS pathogens	2011	54
immune+or+immune+system	21628667	920	Chun TW	Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.	The Journal of infectious diseases	2011	58
immune+or+immune+system	21690402	920	Josefsson L	Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.	Proceedings of the National Academy of Sciences of the United States of America	2011	75
immune+or+immune+system	21690475	920	Slingluff CL Jr	Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.	Journal of clinical oncology 	2011	37
immune+or+immune+system	21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
immune+or+immune+system	21750419	920	Ellis RJ	CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.	AIDS	2011	98
immune+or+immune+system	21782230	920	Dixon AE	Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.	The Journal of allergy and clinical immunology	2011	66
immune+or+immune+system	21811403	920	Rosen S	Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.	PLoS medicine	2011	306
immune+or+immune+system	21836524	920	Govindasamy D	Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata.	Journal of acquired immune deficiency syndromes	2011	39
immune+or+immune+system	21846636	920	Hoft DF	Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.	The Journal of infectious diseases	2011	57
immune+or+immune+system	21857356	920	Faal M	Providing immediate CD4 count results at HIV testing improves ART initiation.	Journal of acquired immune deficiency syndromes	2011	49
immune+or+immune+system	21857654	920	Sullivan NJ	CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.	Nature medicine	2011	61
immune+or+immune+system	21881481	920	Hunt PW	Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.	AIDS	2011	87
immune+or+immune+system	21908576	920	Iyer JG	Merkel cell polyomavirus-specific CD8‚Å∫ and CD4‚Å∫ T-cell responses identified in Merkel cell carcinomas and blood.	Clinical cancer research 	2011	36
immune+or+immune+system	21909029	920	Diaw PA	Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.	Journal of acquired immune deficiency syndromes	2011	36
immune+or+immune+system	21917895	920	Lederman MM	Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.	The Journal of infectious diseases	2011	93
immune+or+immune+system	21963677	920	Kreijtz JH	Immune responses to influenza virus infection.	Virus research	2011	63
immune+or+immune+system	22010913	920	Blanc FX	Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.	The New England journal of medicine	2011	175
immune+or+immune+system	22010914	920	Havlir DV	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.	The New England journal of medicine	2011	172
immune+or+immune+system	22010915	920	Abdool Karim SS	Integration of antiretroviral therapy with tuberculosis treatment.	The New England journal of medicine	2011	138
immune+or+immune+system	22067665	920	Wandeler G	Outcomes of antiretroviral treatment programs in rural Southern Africa.	Journal of acquired immune deficiency syndromes	2012	35
immune+or+immune+system	22101430	920	Waggoner SN	Natural killer cells act as rheostats modulating antiviral T cells.	Nature	2011	142
immune+or+immune+system	22156912	920	Rich ML	Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.	Journal of acquired immune deficiency syndromes	2012	55
immune+or+immune+system	22160724	920	Aubert RD	Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
immune+or+immune+system	22170955	920	Tang Q	CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.	Journal of molecular cell biology	2012	54
immune+or+immune+system	22174559	920	Marshall NB	Cytotoxic CD4 T cells in antiviral immunity.	Journal of biomedicine and biotechnology	2011	52
immune+or+immune+system	22213804	920	Schulze Zur Wiesch J	Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.	The Journal of experimental medicine	2012	51
immune+or+immune+system	22219223	920	Mahnke YD	Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.	Blood	2012	36
immune+or+immune+system	22240256	920	Witwer KW	Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.	Retrovirology	2012	49
immune+or+immune+system	22267016	920	Hall HI	Retention in care of adults and adolescents living with HIV in 13 U.S. areas.	Journal of acquired immune deficiency syndromes	2012	60
immune+or+immune+system	22275401	920	O'Hara GA	Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.	The Journal of infectious diseases	2012	70
immune+or+immune+system	22275402	920	Durand CM	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.	The Journal of infectious diseases	2012	40
immune+or+immune+system	22282593	920	Couser WG	Basic and translational concepts of immune-mediated glomerular diseases.	Journal of the American Society of Nephrology 	2012	35
immune+or+immune+system	22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
immune+or+immune+system	22291913	920	Lassen KG	A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.	PloS one	2012	42
immune+or+immune+system	22327072	920	Kwok WW	Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.	Journal of immunology	2012	36
immune+or+immune+system	22354001	920	Pegram HJ	Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.	Blood	2012	114
immune+or+immune+system	22406268	920	Shan L	Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.	Immunity	2012	263
immune+or+immune+system	22433846	920	Fox MP	Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.	Journal of acquired immune deficiency syndromes	2012	47
immune+or+immune+system	22531758	920	Fleishman JA	Establishment, retention, and loss to follow-up in outpatient HIV care.	Journal of acquired immune deficiency syndromes	2012	64
immune+or+immune+system	22549246	920	Craft JE	Follicular helper T cells in immunity and systemic autoimmunity.	Nature reviews. Rheumatology	2012	70
immune+or+immune+system	22553251	920	Scholler J	Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.	Science translational medicine	2012	143
immune+or+immune+system	22645358	920	Archin NM	Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.	Proceedings of the National Academy of Sciences of the United States of America	2012	81
immune+or+immune+system	22659650	920	Larson BA	Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa.	Journal of acquired immune deficiency syndromes	2012	43
immune+or+immune+system	22673491	920	Damjanovic D	Immunopathology in influenza virus infection: uncoupling the friend from foe.	Clinical immunology	2012	37
immune+or+immune+system	22837004	920	Archin NM	Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.	Nature	2012	340
immune+or+immune+system	22837174	920	Czajkowsky DM	Fc-fusion proteins: new developments and future perspectives.	EMBO molecular medicine	2012	42
immune+or+immune+system	22949321	920	Huh JR	Small molecule inhibitors of RORŒ≥t: targeting Th17 cells and other applications.	European journal of immunology	2012	33
immune+or+immune+system	22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
immune+or+immune+system	22999944	920	Eisele E	Redefining the viral reservoirs that prevent HIV-1 eradication.	Immunity	2012	116
immune+or+immune+system	23011400	920	Clouse K	Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa.	Journal of acquired immune deficiency syndromes	2013	30
immune+or+immune+system	23075916	920	Dalal W	Home-based HIV testing and counseling in rural and urban Kenyan communities.	Journal of acquired immune deficiency syndromes	2013	45
immune+or+immune+system	23148285	920	Nayak JL	CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.	The Journal of infectious diseases	2013	27
immune+or+immune+system	23175374	920	Pegu P	Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.	Journal of virology	2013	49
immune+or+immune+system	23187940	920	Leroy V	Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.	Journal of acquired immune deficiency syndromes	2013	32
immune+or+immune+system	23254153	920	Abraham AG	Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.	Journal of acquired immune deficiency syndromes	2013	36
immune+or+immune+system	23283367	920	Garc√≠a F	A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.	Science translational medicine	2013	46
immune+or+immune+system	23292280	920	Yang M	Regulatory B cells in autoimmune diseases.	Cellular and molecular immunology	2013	38
immune+or+immune+system	23323898	920	Le T	Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.	The New England journal of medicine	2013	117
immune+or+immune+system	23345163	920	Tel J	Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.	Cancer research	2013	51
immune+or+immune+system	23395677	920	Su LF	Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.	Immunity	2013	113
immune+or+immune+system	23408629	920	Dahabieh MS	A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.	Journal of virology	2013	25
immune+or+immune+system	23429504	920	Geng EH	Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.	Journal of acquired immune deficiency syndromes	2013	37
immune+or+immune+system	23435170	920	van Heijst JW	Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.	Nature medicine	2013	47
immune+or+immune+system	23459007	920	Eriksson S	Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.	PLoS pathogens	2013	157
immune+or+immune+system	23525034	920	Chang CC	Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.	AIDS	2013	27
immune+or+immune+system	23700649	920	-			2012	129
immune+or+immune+system	23707039	920	Simmons SB	Modeling the heterogeneity of multiple sclerosis in animals.	Trends in immunology	2013	41
immune+or+immune+system	23719296	920	Younan PM	Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.	Blood	2013	31
immune+or+immune+system	23732522	920	Pan X	Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.	Cell research	2013	28
immune+or+immune+system	23737751	920	Laird GM	Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.	PLoS pathogens	2013	58
immune+or+immune+system	23772614	920	Okoye AA	CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.	Immunological reviews	2013	54
immune+or+immune+system	23772616	920	Paiardini M	HIV-associated chronic immune activation.	Immunological reviews	2013	47
immune+or+immune+system	23794702	920	Nagaraj S	Reciprocal relationship between myeloid-derived suppressor cells and T cells.	Journal of immunology	2013	38
immune+or+immune+system	23818847	920	Josefsson L	Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.	PLoS pathogens	2013	33
immune+or+immune+system	23852127	920	Jain V	Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.	The Journal of infectious diseases	2013	83
immune+or+immune+system	23886064	920	Lederman MM	Residual immune dysregulation syndrome in treated HIV infection.	Advances in immunology	2013	68
immune+or+immune+system	23921881	920	Mocroft A	The incidence of AIDS-defining illnesses at a current CD4 count ‚â• 200 cells/ŒºL in the post-combination antiretroviral therapy era.	Clinical infectious diseases 	2013	26
immune+or+immune+system	23943825	920	Grant PM	Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.	Clinical infectious diseases 	2013	29
immune+or+immune+system	23950730	920	Absher DM	Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations.	PLoS genetics	2013	70
immune+or+immune+system	24041796	920	Naranbhai V	Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.	The Journal of infectious diseases	2014	21
immune+or+immune+system	24045046	920	Jane-Wit D	Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-Œ∫B signaling in endothelial cells.	Circulation	2013	28
immune+or+immune+system	24064670	920	Turner DL	Lung niches for the generation and maintenance of tissue-resident memory T cells.	Mucosal immunology	2014	58
immune+or+immune+system	24097267	920	Buenrostro JD	Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.	Nature methods	2013	375
immune+or+immune+system	24121761	920	Gray KM	Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States.	Journal of acquired immune deficiency syndromes	2014	21
immune+or+immune+system	24129370	920	Yehia BR	Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.	Journal of acquired immune deficiency syndromes	2014	21
immune+or+immune+system	24180001	920	P√©rez-Santiago J	Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.	AIDS	2013	28
immune+or+immune+system	24184682	920	Lindemans CA	Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.	Blood	2014	23
immune+or+immune+system	24185941	920	Krishnan S	Evidence for innate immune system activation in HIV type 1-infected elite controllers.	The Journal of infectious diseases	2014	40
immune+or+immune+system	24204277	920	Wibmer CK	Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.	PLoS pathogens	2013	65
immune+or+immune+system	24225944	920	Kanakry CG	Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.	Science translational medicine	2013	45
immune+or+immune+system	24226057	920	Luetkemeyer AF	Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.	Journal of acquired immune deficiency syndromes	2014	21
immune+or+immune+system	24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
immune+or+immune+system	24419071	920	IeDEA and ART Cohort Collaborations.	Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2014	43
immune+or+immune+system	24442222	920	Silverberg MJ	Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care.	Journal of acquired immune deficiency syndromes	2014	29
immune+or+immune+system	24448112	920	Wang S	Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care.	Scientific reports	2014	22
immune+or+immune+system	24497929	920	Serrano-Villar S	Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.	PloS one	2014	32
immune+or+immune+system	24501199	920	Wertheimer AM	Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans.	Journal of immunology	2014	40
immune+or+immune+system	24620025	920	Archin NM	HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.	The Journal of infectious diseases	2014	75
immune+or+immune+system	24675585	920	Nakiyingi L	Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.	Journal of acquired immune deficiency syndromes	2014	31
immune+or+immune+system	24706775	920	Cillo AR	Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	73
immune+or+immune+system	24759213	920	Kumar A	HIV-1 latency in monocytes/macrophages.	Viruses	2014	37
immune+or+immune+system	24763540	920	Somers EC	Environmental exposures, epigenetic changes and the risk of lupus.	Lupus	2014	20
immune+or+immune+system	24786080	920	Raj T	Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.	Science	2014	90
immune+or+immune+system	24814848	920	Grant I	Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.	Neurology	2014	52
immune+or+immune+system	24965451	920	Buzon MJ	Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.	Journal of virology	2014	52
immune+or+immune+system	24977376	920	Clouse K	"What they wanted was to give birth; nothing else": barriers to retention in option B+ HIV care among postpartum women in South Africa.	Journal of acquired immune deficiency syndromes	2014	33
immune+or+immune+system	25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
immune+or+immune+system	25056899	920	Arenaccio C	Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.	Journal of virology	2014	28
immune+or+immune+system	25101191	920	G√°lvez J	Role of Th17 Cells in the Pathogenesis of Human IBD.	ISRN inflammation	2014	23
immune+or+immune+system	25187662	920	Derhovanessian E	Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly.	Journal of immunology	2014	23
immune+or+immune+system	25253353	920	Soriano-Sarabia N	Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.	Journal of virology	2014	26
immune+or+immune+system	25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
immune+or+immune+system	25277040	920	Lueg G	Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.	Neurobiology of aging	2015	20
immune+or+immune+system	25363779	920	Farh KK	Genetic and epigenetic fine mapping of causal autoimmune disease variants.	Nature	2015	216
immune+or+immune+system	25378643	920	Adusumilli PS	Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.	Science translational medicine	2014	62
immune+or+immune+system	25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4‚Å∫ memory T Cells.	Nature communications	2014	27
immune+or+immune+system	25426834	920	Ledgerwood JE	Chimpanzee Adenovirus Vector Ebola Vaccine.	The New England journal of medicine	2017	37
immune+or+immune+system	25447326	920	Smith JA	Update on ankylosing spondylitis: current concepts in pathogenesis.	Current allergy and asthma reports	2015	16
immune+or+immune+system	25477212	920	Becattini S	T cell immunity. Functional heterogeneity of human memory CD4‚Å∫ T cell clones primed by pathogens or vaccines.	Science	2015	44
immune+or+immune+system	25501345	920	Koller M	Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2015	17
immune+or+immune+system	25586559	920	Klase Z	Dysbiotic bacteria translocate in progressive SIV infection.	Mucosal immunology	2015	28
immune+or+immune+system	25589335	920	Sung JA	Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir.	The Journal of infectious diseases	2015	25
immune+or+immune+system	25593279	920	Hofmann U	Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction.	Circulation research	2015	20
immune+or+immune+system	25594465	920	Ueno H	Pathophysiology of T follicular helper cells in humans and mice.	Nature immunology	2015	60
immune+or+immune+system	25681373	920	Fouts TR	Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
immune+or+immune+system	25706232	920	Osinusi A	Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.	JAMA	2015	41
immune+or+immune+system	25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
immune+or+immune+system	25726088	920	Ndiaye BP	Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.	The Lancet. Respiratory medicine	2015	24
immune+or+immune+system	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
immune+or+immune+system	25882821	920	Friis-M√∏ller N	An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.	European journal of preventive cardiology	2016	14
immune+or+immune+system	25888703	920	Goronzy JJ	Naive T cell maintenance and function in human aging.	Journal of immunology	2015	22
immune+or+immune+system	25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4‚Å∫ T cells.	Science	2015	46
immune+or+immune+system	25967273	920	Wang Z	Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8‚Å∫ T cells.	Nature communications	2015	19
immune+or+immune+system	26041300	920	Saunders KO	Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.	Journal of virology	2015	19
immune+or+immune+system	26044074	920	Pera A	Immunosenescence: Implications for response to infection and vaccination in older people.	Maturitas	2015	25
immune+or+immune+system	26067822	920	Chavez L	HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.	PLoS pathogens	2015	27
immune+or+immune+system	26130226	920	Lu W	CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.	Journal of the International AIDS Society	2015	17
immune+or+immune+system	26169416	920	Spivak AM	Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.	Antimicrobial agents and chemotherapy	2015	20
immune+or+immune+system	26193635	920	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	20
immune+or+immune+system	26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
immune+or+immune+system	26369987	920	Sommermeyer D	Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.	Leukemia	2016	45
immune+or+immune+system	26405463	920	Kumar A	Epigenetic control of HIV-1 post integration latency: implications for therapy.	Clinical epigenetics	2015	17
immune+or+immune+system	26424550	920	Mussini C	CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.	The lancet. HIV	2015	21
immune+or+immune+system	26452565	920	Younas M	Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.	HIV medicine	2016	16
immune+or+immune+system	26459351	920	Schulz AR	Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans.	Journal of immunology	2015	17
immune+or+immune+system	26657141	920	Thome JJ	Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.	Nature medicine	2016	24
immune+or+immune+system	26724103	920	Hohlfeld R	The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.	The Lancet. Neurology	2016	13
immune+or+immune+system	26743582	920	Ondondo B	Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.	Molecular therapy 	2016	13
immune+or+immune+system	26842680	920	Muller L	Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.	Scientific reports	2016	14
immune+or+immune+system	26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
immune+or+immune+system	26885861	920	Procaccini C	The Proteomic Landscape of Human Ex¬†Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.	Immunity	2016	17
immune+or+immune+system	26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
immune+or+immune+system	26962942	920	Monaco CL	Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.	Cell host and microbe	2016	24
immune+or+immune+system	27019159	920	Bakulski KM	DNA methylation of cord blood cell types: Applications for mixed cell birth studies.	Epigenetics	2016	23
immune+or+immune+system	27199430	920	Lu CL	Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.	Science	2016	37
immune+or+immune+system	27222480	920	Krejcik J	Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.	Blood	2016	17
immune+or+immune+system	27605551	920	Turtle CJ	Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.	Science translational medicine	2016	19
immune+or+immune+system	27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Œ±4Œ≤7 antibody therapy.	Science	2016	20
immune+or+immune+system	28199305	920	Mordm√ºller B	Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.	Nature	2017	10
infectious+or+infection	1322294	920	Lewis P	Human immunodeficiency virus infection of cells arrested in the cell cycle.	The EMBO journal	1992	180
infectious+or+infection	1361652	920	-	1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.	MMWR. Recommendations and reports 	1992	637
infectious+or+infection	1433512	920	Willey RL	Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.	Journal of virology	1992	204
infectious+or+infection	2214018	920	Page KA	Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.	Journal of virology	1990	144
infectious+or+infection	2395859	920	Daar ES	High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.	Proceedings of the National Academy of Sciences of the United States of America	1990	162
infectious+or+infection	2564898	920	Tersmette M	Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.	Journal of virology	1989	210
infectious+or+infection	2665081	920	Schnittman SM	The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.	Science	1989	173
infectious+or+infection	2760980	920	Kim SY	Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.	Journal of virology	1989	230
infectious+or+infection	3257102	920	Willey RL	In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.	Journal of virology	1988	319
infectious+or+infection	3277274	920	Fauci AS	The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.	Science	1988	292
infectious+or+infection	3299089	920	Fischl MA	The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	269
infectious+or+infection	6096719	920	Dalgleish AG	The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.	Nature	1984	854
infectious+or+infection	7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
infectious+or+infection	7738173	920	Roederer M	CD8 naive T cell counts decrease progressively in HIV-infected adults.	The Journal of clinical investigation	1995	130
infectious+or+infection	7935654	920	Connor EM	Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.	The New England journal of medicine	1994	399
infectious+or+infection	8095306	920	Connor RI	Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.	Journal of virology	1993	135
infectious+or+infection	8096068	920	Embretson J	Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.	Nature	1993	306
infectious+or+infection	8124721	920	Aiken C	Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain.	Cell	1994	235
infectious+or+infection	8187174	920	York IA	A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.	Cell	1994	164
infectious+or+infection	8445728	920	Dimitrov DS	Quantitation of human immunodeficiency virus type 1 infection kinetics.	Journal of virology	1993	200
infectious+or+infection	8614801	920	Wolinsky SM	Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.	Science	1996	176
infectious+or+infection	9105756	920	Alvar J	Leishmania and human immunodeficiency virus coinfection: the first 10 years.	Clinical microbiology reviews	1997	111
infectious+or+infection	9188531	920	Orenstein JM	Macrophages as a source of HIV during opportunistic infections.	Science	1997	152
infectious+or+infection	9217758	920	Cohen MS	Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.	Lancet	1997	181
infectious+or+infection	9287227	920	Hammer SM	A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.	The New England journal of medicine	1997	394
infectious+or+infection	9287228	920	Gulick RM	Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.	The New England journal of medicine	1997	297
infectious+or+infection	9371822	920	Chun TW	Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	1997	463
infectious+or+infection	9466638	920	Hogg RS	Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.	JAMA	1998	159
infectious+or+infection	9516219	920	Palella FJ Jr	Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.	The New England journal of medicine	1998	1574
infectious+or+infection	9525993	920	Koelle DM	Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.	The Journal of clinical investigation	1998	103
infectious+or+infection	10037100	920	Palefsky JM	Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.	Journal of the National Cancer Institute	1999	118
infectious+or+infection	10196297	920	Mascola JR	Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.	Journal of virology	1999	336
infectious+or+infection	10232311	920	Anglaret X	Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C√¥te d'Ivoire: a randomised trial. Cotrimo-CI Study Group.	Lancet	1999	104
infectious+or+infection	10232312	920	Wiktor SZ	Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C√¥te d'Ivoire: a randomised controlled trial.	Lancet	1999	106
infectious+or+infection	10341272	920	Zhang L	Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.	The New England journal of medicine	1999	195
infectious+or+infection	10386555	920	Shapiro MF	Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.	JAMA	1999	194
infectious+or+infection	10419445	920	Lucas GM	Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.	Annals of internal medicine	1999	141
infectious+or+infection	10498659	920	Benhamou Y	Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.	Hepatology	1999	208
infectious+or+infection	10500077	920	Gerlach JT	Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.	Gastroenterology	1999	163
infectious+or+infection	10607709	920	Hazenberg MD	T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).	Blood	2000	129
infectious+or+infection	10770911	920	Kaplan JE	Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.	Clinical infectious diseases 	2000	115
infectious+or+infection	10837072	920	Pierson T	Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.	Annual review of immunology	2000	162
infectious+or+infection	10877736	920	Paterson DL	Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.	Annals of internal medicine	2000	674
infectious+or+infection	11009139	920	Whitworth J	Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.	Lancet	2000	106
infectious+or+infection	11117912	920	Greub G	Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.	Lancet	2000	151
infectious+or+infection	11248160	920	Freedberg KA	The cost effectiveness of combination antiretroviral therapy for HIV disease.	The New England journal of medicine	2001	109
infectious+or+infection	11309627	920	McCune JM	The dynamics of CD4+ T-cell depletion in HIV disease.	Nature	2001	151
infectious+or+infection	11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
infectious+or+infection	11434728	920	Murphy EL	Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.	Annals of internal medicine	2001	121
infectious+or+infection	11483742	920	Janini M	Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.	Journal of virology	2001	88
infectious+or+infection	11500352	920	Retamales I	Amplification of inflammation in emphysema and its association with latent adenoviral infection.	American journal of respiratory and critical care medicine	2001	91
infectious+or+infection	11585784	920	Lawn SD	Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.	Clinical microbiology reviews	2001	88
infectious+or+infection	11672548	920	Eckstein DA	HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.	Immunity	2001	106
infectious+or+infection	11696593	920	Mohri H	Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.	The Journal of experimental medicine	2001	105
infectious+or+infection	11711588	920	Betts MR	Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.	Journal of virology	2001	251
infectious+or+infection	11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
infectious+or+infection	11752161	920	Zhu T	Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.	Journal of virology	2002	115
infectious+or+infection	11794218	920	Gortmaker SL	Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.	The New England journal of medicine	2001	99
infectious+or+infection	11861835	920	Edwards TG	Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.	Journal of virology	2002	92
infectious+or+infection	11873003	920	Morgan D	HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?	AIDS	2002	89
infectious+or+infection	11917238	920	Giorgi JV	Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.	Journal of acquired immune deficiency syndromes	2002	96
infectious+or+infection	11953469	920	French N	Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.	AIDS	2002	100
infectious+or+infection	12086758	920	Badri M	Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.	Lancet	2002	145
infectious+or+infection	12126821	920	Egger M	Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.	Lancet	2002	381
infectious+or+infection	12131186	920	Ling B	SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.	AIDS	2002	89
infectious+or+infection	12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
infectious+or+infection	12393849	920	Schacker TW	Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.	The Journal of clinical investigation	2002	82
infectious+or+infection	12409739	920	Howard AA	A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.	AIDS	2002	87
infectious+or+infection	12411292	920	Gamadia LE	Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.	Blood	2003	108
infectious+or+infection	12491162	920	Sacktor N	The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.	Journal of neurovirology	2002	109
infectious+or+infection	12493258	920	Thio CL	HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).	Lancet	2002	211
infectious+or+infection	12524385	920	Douek DC	T cell dynamics in HIV-1 infection.	Annual review of immunology	2003	185
infectious+or+infection	12552096	920	Chun TW	Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.	Proceedings of the National Academy of Sciences of the United States of America	2003	76
infectious+or+infection	12637625	920	Lalezari JP	Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.	The New England journal of medicine	2003	148
infectious+or+infection	12648460	920	Silvestri G	Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.	Immunity	2003	257
infectious+or+infection	12693883	920	Palella FJ Jr	Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.	Annals of internal medicine	2003	109
infectious+or+infection	12721933	920	Hunt PW	T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.	The Journal of infectious diseases	2003	296
infectious+or+infection	12805437	920	Hermankova M	Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.	Journal of virology	2003	81
infectious+or+infection	12960820	920	Hazenberg MD	Persistent immune activation in HIV-1 infection is associated with progression to AIDS.	AIDS	2003	255
infectious+or+infection	14557216	920	Kaufmann GR	CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.	Archives of internal medicine	2003	85
infectious+or+infection	14557656	920	Guadalupe M	Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.	Journal of virology	2003	336
infectious+or+infection	14610491	920	Shearer WT	Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.	The Journal of allergy and clinical immunology	2003	152
infectious+or+infection	14722271	920	Brenchley JM	T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.	Journal of virology	2004	161
infectious+or+infection	14966528	920	Papagno L	Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.	PLoS biology	2004	124
infectious+or+infection	15023877	920	Hsue PY	Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.	Circulation	2004	148
infectious+or+infection	15034567	920	Reece WH	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.	Nature medicine	2004	86
infectious+or+infection	15060436	920	Coetzee D	Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.	AIDS	2004	207
infectious+or+infection	15117761	920	Deeks SG	Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.	Blood	2004	289
infectious+or+infection	15163705	920	Han Y	Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.	Journal of virology	2004	127
infectious+or+infection	15210746	920	Matano T	Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.	The Journal of experimental medicine	2004	89
infectious+or+infection	15229304	920	Fawzi WW	A randomized trial of multivitamin supplements and HIV disease progression and mortality.	The New England journal of medicine	2004	81
infectious+or+infection	15234856	920	Ledergerber B	Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.	Lancet	2004	75
infectious+or+infection	15247338	920	Lallemant M	Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.	The New England journal of medicine	2004	104
infectious+or+infection	15247339	920	Jourdain G	Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.	The New England journal of medicine	2004	105
infectious+or+infection	15247437	920	Hazuda DJ	Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.	Science	2004	73
infectious+or+infection	15280419	920	Kinter AL	CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.	The Journal of experimental medicine	2004	159
infectious+or+infection	15327410	920	Szczech LA	The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.	Kidney international	2004	80
infectious+or+infection	15362047	920	Lauer GM	High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.	Gastroenterology	2004	96
infectious+or+infection	15365130	920	Valcour V	Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.	Neurology	2004	131
infectious+or+infection	15376257	920	Ulrichs T	Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung.	The Journal of pathology	2004	82
infectious+or+infection	15464184	920	Newell ML	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.	Lancet	2004	324
infectious+or+infection	15488218	920	Mermin J	Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.	Lancet	2004	109
infectious+or+infection	15545358	920	Messaoudi I	Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense.	The Journal of experimental medicine	2004	72
infectious+or+infection	15555666	920	Chintu C	Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.	Lancet	2004	96
infectious+or+infection	15577629	920	Buchacz K	Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections.	AIDS	2004	92
infectious+or+infection	15652606	920	Kublin JG	Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.	Lancet	2005	86
infectious+or+infection	15703422	920	Sanders GD	Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.	The New England journal of medicine	2005	159
infectious+or+infection	15793563	920	Mattapallil JJ	Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.	Nature	2005	557
infectious+or+infection	15827153	920	Nobile C	Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.	Journal of virology	2005	65
infectious+or+infection	15840880	920	Strickler HD	Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.	Journal of the National Cancer Institute	2005	162
infectious+or+infection	15983918	920	Ivers LC	Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.	Clinical infectious diseases 	2005	119
infectious+or+infection	15994817	920	Reynolds MR	CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little.	Journal of virology	2005	75
infectious+or+infection	16093359	920	Pudney J	Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.	Biology of reproduction	2005	105
infectious+or+infection	16103772	920	Palefsky JM	Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.	AIDS	2005	67
infectious+or+infection	16116308	920	Fleishman JA	Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.	Medical care	2005	74
infectious+or+infection	16116467	920	Klenerman P	T cells and viral persistence: lessons from diverse infections.	Nature immunology	2005	132
infectious+or+infection	16147978	920	Sylwester AW	Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.	The Journal of experimental medicine	2005	363
infectious+or+infection	16182404	920	Br√§u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
infectious+or+infection	16227428	920	Thompson PM	Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.	Proceedings of the National Academy of Sciences of the United States of America	2005	117
infectious+or+infection	16276421	920	Chun TW	HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.	The Journal of clinical investigation	2005	117
infectious+or+infection	16284464	920	Lawn SD	Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.	AIDS	2005	172
infectious+or+infection	16319381	920	Severe P	Antiretroviral therapy in a thousand patients with AIDS in Haiti.	The New England journal of medicine	2005	99
infectious+or+infection	16327318	920	Wools-Kaloustian K	Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.	AIDS	2006	107
infectious+or+infection	16339561	920	Fletcher JM	Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.	Journal of immunology	2005	66
infectious+or+infection	16364740	920	Yamashita M	Retroviral infection of non-dividing cells: old and new perspectives.	Virology	2006	75
infectious+or+infection	16421366	920	Gallant JE	Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.	The New England journal of medicine	2006	193
infectious+or+infection	16482171	920	Brenchley JM	HIV disease: fallout from a mucosal catastrophe?	Nature immunology	2006	197
infectious+or+infection	16549832	920	Engels EA	Elevated incidence of lung cancer among HIV-infected individuals.	Journal of clinical oncology 	2006	77
infectious+or+infection	16631548	920	Battegay M	Immunological recovery and antiretroviral therapy in HIV-1 infection.	The Lancet. Infectious diseases	2006	61
infectious+or+infection	16631881	920	Mermin J	Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.	Lancet	2006	74
infectious+or+infection	16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
infectious+or+infection	16670804	920	Bekker LG	Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.	South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde	2006	66
infectious+or+infection	16691070	920	Etard JF	Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.	AIDS	2006	124
infectious+or+infection	16735692	920	Mattapallil JJ	Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge.	The Journal of experimental medicine	2006	80
infectious+or+infection	16753288	920	Picker LJ	Immunopathogenesis of acute AIDS virus infection.	Current opinion in immunology	2006	73
infectious+or+infection	16763152	920	Letvin NL	Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.	Science	2006	178
infectious+or+infection	16824132	920	Harari A	Functional signatures of protective antiviral T-cell immunity in human virus infections.	Immunological reviews	2006	104
infectious+or+infection	16878047	920	Palella FJ Jr	Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.	Journal of acquired immune deficiency syndromes	2006	382
infectious+or+infection	16885778	920	Manosuthi W	Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2006	91
infectious+or+infection	16905783	920	Gulick RM	Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.	JAMA	2006	75
infectious+or+infection	16905788	920	Hammer SM	Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.	JAMA	2006	160
infectious+or+infection	17063130	920	Schackman BR	The lifetime cost of current human immunodeficiency virus care in the United States.	Medical care	2006	144
infectious+or+infection	17090675	920	Levine BL	Gene transfer in humans using a conditionally replicating lentiviral vector.	Proceedings of the National Academy of Sciences of the United States of America	2006	159
infectious+or+infection	17135583	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	CD4+ count-guided interruption of antiretroviral treatment.	The New England journal of medicine	2006	629
infectious+or+infection	17217334	920	Lackner AA	Current concepts in AIDS pathogenesis: insights from the SIV/macaque model.	Annual review of medicine	2007	59
infectious+or+infection	17224919	920	Han Y	Experimental approaches to the study of HIV-1 latency.	Nature reviews. Microbiology	2007	91
infectious+or+infection	17255740	920	Lawn SD	Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.	AIDS	2007	112
infectious+or+infection	17258731	920	von Hahn T	Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.	Gastroenterology	2007	144
infectious+or+infection	17267500	920	Chaudhuri R	Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor.	Journal of virology	2007	83
infectious+or+infection	17357054	920	Baeten JM	HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.	The Journal of infectious diseases	2007	81
infectious+or+infection	17457094	920	Szczech LA	Microalbuminuria in HIV infection.	AIDS	2007	58
infectious+or+infection	17492591	920	Chun TW	Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.	The Journal of infectious diseases	2007	72
infectious+or+infection	17503751	920	Orrell C	Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.	Antiviral therapy	2007	57
infectious+or+infection	17554710	920	Kirk GD	HIV infection is associated with an increased risk for lung cancer, independent of smoking.	Clinical infectious diseases 	2007	120
infectious+or+infection	17620755	920	Palombi L	Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.	AIDS	2007	58
infectious+or+infection	17659333	920	Mocroft A	Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.	Lancet	2007	62
infectious+or+infection	17709519	920	Milush JM	Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.	Journal of immunology	2007	65
infectious+or+infection	17713158	920	Boulle A	Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.	Antiviral therapy	2007	58
infectious+or+infection	17728240	920	Chen P	Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.	Journal of virology	2007	172
infectious+or+infection	17894380	920	Bhaskaran K	Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.	Annals of neurology	2008	55
infectious+or+infection	17913974	920	Venet F	Regulatory T cell populations in sepsis and trauma.	Journal of leukocyte biology	2008	56
infectious+or+infection	17916442	920	Boasso A	Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.	Clinical immunology	2008	78
infectious+or+infection	17954540	920	Bolton-Moore C	Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.	JAMA	2007	156
infectious+or+infection	17959677	920	Sankaran S	Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.	Journal of virology	2008	82
infectious+or+infection	17986574	920	Koch S	Cytomegalovirus infection: a driving force in human T cell immunosenescence.	Annals of the New York Academy of Sciences	2007	62
infectious+or+infection	18025885	920	Moh R	Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.	AIDS	2007	62
infectious+or+infection	18171295	920	Hunt PW	Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.	The Journal of infectious diseases	2008	248
infectious+or+infection	18190322	920	Goulet JL	Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?	Clinical infectious diseases 	2007	99
infectious+or+infection	18198941	920	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	154
infectious+or+infection	18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
infectious+or+infection	18240953	920	Moir S	Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.	The Journal of infectious diseases	2008	62
infectious+or+infection	18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
infectious+or+infection	18266607	920	Kiwanuka N	Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.	The Journal of infectious diseases	2008	101
infectious+or+infection	18382686	920	Funderburg N	Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.	PloS one	2008	60
infectious+or+infection	18427202	920	Baker JV	CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.	AIDS	2008	106
infectious+or+infection	18440426	920	Phillips AN	Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.	Lancet	2008	77
infectious+or+infection	18476292	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.	The Journal of infectious diseases	2008	123
infectious+or+infection	18476293	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.	The Journal of infectious diseases	2008	59
infectious+or+infection	18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
infectious+or+infection	18494555	920	Bisson GP	Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.	PLoS medicine	2008	68
infectious+or+infection	18505169	920	Phillips AN	Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.	Antiviral therapy	2008	59
infectious+or+infection	18525258	920	Archin NM	Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.	AIDS	2008	84
infectious+or+infection	18579608	920	Chase AJ	Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.	Journal of virology	2008	59
infectious+or+infection	18598193	920	Estes J	Collagen deposition limits immune reconstitution in the gut.	The Journal of infectious diseases	2008	63
infectious+or+infection	18664624	920	Brenchley JM	Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.	Blood	2008	245
infectious+or+infection	18677028	920	Hammer SM	Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.	JAMA	2008	294
infectious+or+infection	18765698	920	SMART Study Group.	Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.	Annals of internal medicine	2008	66
infectious+or+infection	18784453	920	Lawn SD	Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.	AIDS	2008	303
infectious+or+infection	18981768	920	Nash D	Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.	AIDS	2008	80
infectious+or+infection	18981769	920	Bussmann H	Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.	AIDS	2008	72
infectious+or+infection	19020325	920	Violari A	Early antiretroviral therapy and mortality among HIV-infected infants.	The New England journal of medicine	2008	388
infectious+or+infection	19072715	920	Mugavero MJ	Missed visits and mortality among patients establishing initial outpatient HIV treatment.	Clinical infectious diseases 	2009	134
infectious+or+infection	19079157	920	Brenchley JM	HIV infection and the gastrointestinal immune system.	Mucosal immunology	2008	132
infectious+or+infection	19079215	920	Macal M	Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.	Mucosal immunology	2008	81
infectious+or+infection	19114870	920	Lawn SD	Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa.	AIDS	2009	71
infectious+or+infection	19123865	920	Robbins GK	Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.	Clinical infectious diseases 	2009	73
infectious+or+infection	19123868	920	Gazzola L	The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.	Clinical infectious diseases 	2009	65
infectious+or+infection	19144703	920	Duverger A	Determinants of the establishment of human immunodeficiency virus type 1 latency.	Journal of virology	2009	58
infectious+or+infection	19223334	920	Chi BH	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.	International journal of epidemiology	2009	48
infectious+or+infection	19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
infectious+or+infection	19307857	920	Ettenhofer ML	Aging, neurocognition, and medication adherence in HIV infection.	The American journal of geriatric psychiatry 	2009	47
infectious+or+infection	19339714	920	Kitahata MM	Effect of early versus deferred antiretroviral therapy for HIV on survival.	The New England journal of medicine	2009	383
infectious+or+infection	19383966	920	Hasegawa A	The level of monocyte turnover predicts disease progression in the macaque model of AIDS.	Blood	2009	61
infectious+or+infection	19390417	920	Hsue PY	Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.	AIDS	2009	123
infectious+or+infection	19444075	920	Grabar S	Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.	AIDS	2009	50
infectious+or+infection	19461502	920	Lawn SD	Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.	AIDS	2009	103
infectious+or+infection	19504725	920	Bassett IV	Loss to care and death before antiretroviral therapy in Durban, South Africa.	Journal of acquired immune deficiency syndromes	2009	90
infectious+or+infection	19569972	920	Kantor R	Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.	Clinical infectious diseases 	2009	57
infectious+or+infection	19571723	920	Marin B	Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.	AIDS	2009	71
infectious+or+infection	19616720	920	Wawer MJ	Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.	Lancet	2009	96
infectious+or+infection	19620143	920	Walensky RP	When to start antiretroviral therapy in resource-limited settings.	Annals of internal medicine	2009	70
infectious+or+infection	19640996	920	Piantadosi A	Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.	Journal of virology	2009	80
infectious+or+infection	19647202	920	Carson KR	Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.	The Lancet. Oncology	2009	110
infectious+or+infection	19673615	920	Castelnuovo B	Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.	Clinical infectious diseases 	2009	58
infectious+or+infection	19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
infectious+or+infection	19770514	920	Sauce D	Evidence of premature immune aging in patients thymectomized during early childhood.	The Journal of clinical investigation	2009	65
infectious+or+infection	19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
infectious+or+infection	19911963	920	Hoffmann CJ	Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.	Clinical infectious diseases 	2009	53
infectious+or+infection	19923174	920	Doria-Rose NA	Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.	Journal of virology	2010	140
infectious+or+infection	20023438	920	Bassett IV	Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.	AIDS	2010	75
infectious+or+infection	20089951	920	Celum C	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.	The New England journal of medicine	2010	216
infectious+or+infection	20108382	920	Lawn SD	Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.	AIDS	2009	81
infectious+or+infection	20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
infectious+or+infection	20139992	920	Flatz L	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.	Nature medicine	2010	43
infectious+or+infection	20170371	920	Euler Z	Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.	The Journal of infectious diseases	2010	66
infectious+or+infection	20181971	920	Abdool Karim SS	Timing of initiation of antiretroviral drugs during tuberculosis therapy.	The New England journal of medicine	2010	223
infectious+or+infection	20181972	920	Cain KP	An algorithm for tuberculosis screening and diagnosis in people with HIV.	The New England journal of medicine	2010	87
infectious+or+infection	20201977	920	Yi JS	T-cell exhaustion: characteristics, causes and conversion.	Immunology	2010	90
infectious+or+infection	20208541	920	Carter CC	HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.	Nature medicine	2010	112
infectious+or+infection	20234368	920	Daayana S	Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.	British journal of cancer	2010	57
infectious+or+infection	20347483	920	Walker AS	Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.	Lancet	2010	48
infectious+or+infection	20352098	920	Dheda K	Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.	PloS one	2010	47
infectious+or+infection	20380565	920	Antiretroviral Therapy Cohort Collaboration.	Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.	Clinical infectious diseases 	2010	132
infectious+or+infection	20415574	920	Makadzange AT	Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.	Clinical infectious diseases 	2010	55
infectious+or+infection	20453631	920	Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group.	Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.	AIDS	2010	121
infectious+or+infection	20457954	920	Ellis RJ	Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.	Archives of neurology	2010	84
infectious+or+infection	20505494	920	Ford ES	Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.	AIDS	2010	73
infectious+or+infection	20516524	920	Letendre SL	Neurologic complications of HIV disease and their treatment.	Topics in HIV medicine 	2010	84
infectious+or+infection	20537376	920	Donnell D	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.	Lancet	2010	343
infectious+or+infection	20550452	920	Julg B	Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.	Clinical infectious diseases 	2010	49
infectious+or+infection	20554983	920	Shapiro RL	Antiretroviral regimens in pregnancy and breast-feeding in Botswana.	The New England journal of medicine	2010	159
infectious+or+infection	20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
infectious+or+infection	20561080	920	Antinori A	Late presentation of HIV infection: a consensus definition.	HIV medicine	2011	68
infectious+or+infection	20597691	920	Lichtenstein KA	Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.	Clinical infectious diseases 	2010	76
infectious+or+infection	20597693	920	Meya DB	Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count &amp;lt; or = 100 cells/microL who start HIV therapy in resource-limited settings.	Clinical infectious diseases 	2010	78
infectious+or+infection	20610331	920	Lawn SD	Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.	The Lancet. Infectious diseases	2010	56
infectious+or+infection	20617921	920	Walensky RP	Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC.	Clinical infectious diseases 	2010	55
infectious+or+infection	20638120	920	May M	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.	Lancet	2010	103
infectious+or+infection	20647201	920	Severe P	Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.	The New England journal of medicine	2010	136
infectious+or+infection	20683336	920	Selke HM	Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya.	Journal of acquired immune deficiency syndromes	2010	69
infectious+or+infection	20697368	920	Cutler C	Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.	Bone marrow transplantation	2011	38
infectious+or+infection	20711481	920	Gandhi RT	The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.	PLoS medicine	2010	119
infectious+or+infection	20735240	920	Bassett IV	Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.	Clinical infectious diseases 	2010	63
infectious+or+infection	20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
infectious+or+infection	20827216	920	Kranzer K	Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors.	Journal of acquired immune deficiency syndromes	2010	43
infectious+or+infection	20844049	920	Murray SM	Reduction of immune activation with chloroquine therapy during chronic HIV infection.	Journal of virology	2010	48
infectious+or+infection	20859193	920	Gebo KA	Contemporary costs of HIV healthcare in the HAART era.	AIDS	2010	41
infectious+or+infection	20865049	920	Lugada E	Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya.	PloS one	2010	40
infectious+or+infection	20889546	920	Gordon SN	Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.	Journal of immunology	2010	48
infectious+or+infection	20924117	920	Kennedy EM	Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages.	The Journal of biological chemistry	2010	42
infectious+or+infection	20942667	920	Palumbo P	Antiretroviral treatment for children with peripartum nevirapine exposure.	The New England journal of medicine	2010	88
infectious+or+infection	21034222	920	Moir S	Pathogenic mechanisms of HIV disease.	Annual review of pathology	2011	83
infectious+or+infection	21072191	920	Kranzer K	Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.	PloS one	2010	72
infectious+or+infection	21098232	920	Draper SJ	Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.	Journal of immunology	2010	49
infectious+or+infection	21105780	920	Soghoian DZ	Cytolytic CD4(+) T cells in viral immunity.	Expert review of vaccines	2010	48
infectious+or+infection	21173675	920	Koyanagi A	Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.	The Pediatric infectious disease journal	2011	45
infectious+or+infection	21174240	920	Heaton RK	HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.	Journal of neurovirology	2011	438
infectious+or+infection	21217181	920	Crump JA	Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.	Clinical infectious diseases 	2011	48
infectious+or+infection	21220772	920	Kaplan RC	T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.	The Journal of infectious diseases	2011	106
infectious+or+infection	21249232	920	Mikell I	Characteristics of the earliest cross-neutralizing antibody response to HIV-1.	PLoS pathogens	2011	135
infectious+or+infection	21325137	920	Ganesan A	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.	The Journal of infectious diseases	2011	48
infectious+or+infection	21367910	920	Anderson JA	Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.	Journal of virology	2011	38
infectious+or+infection	21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
infectious+or+infection	21398272	920	Young B	Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.	Clinical infectious diseases 	2011	64
infectious+or+infection	21403397	920	Chen H	CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.	The Journal of clinical investigation	2011	69
infectious+or+infection	21412126	920	Appay V	Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.	AIDS	2011	41
infectious+or+infection	21492926	920	Samandari T	6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.	Lancet	2011	94
infectious+or+infection	21494598	920	Merlini E	Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.	PloS one	2011	42
infectious+or+infection	21502083	920	Hunt PW	Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.	The Journal of infectious diseases	2011	98
infectious+or+infection	21502920	920	Okulicz JF	Epidemiology and clinical characteristics of elite controllers.	Current opinion in HIV and AIDS	2011	37
infectious+or+infection	21543722	920	Letvin NL	Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.	Science translational medicine	2011	109
infectious+or+infection	21559280	920	Boyles TH	Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.	PloS one	2011	38
infectious+or+infection	21625591	920	Gallegos AM	A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo.	PLoS pathogens	2011	54
infectious+or+infection	21656145	920	Schwartz SR	High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.	AIDS and behavior	2012	46
infectious+or+infection	21666786	920	Cota GF	Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.	PLoS neglected tropical diseases	2011	40
infectious+or+infection	21690402	920	Josefsson L	Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.	Proceedings of the National Academy of Sciences of the United States of America	2011	75
infectious+or+infection	21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
infectious+or+infection	21737504	920	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	75
infectious+or+infection	21750418	920	Nash D	Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.	AIDS	2011	41
infectious+or+infection	21836524	920	Govindasamy D	Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata.	Journal of acquired immune deficiency syndromes	2011	39
infectious+or+infection	21857654	920	Sullivan NJ	CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.	Nature medicine	2011	61
infectious+or+infection	21890751	920	Mugavero MJ	Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.	Clinical infectious diseases 	2011	41
infectious+or+infection	21917895	920	Lederman MM	Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.	The Journal of infectious diseases	2011	93
infectious+or+infection	21963677	920	Kreijtz JH	Immune responses to influenza virus infection.	Virus research	2011	63
infectious+or+infection	21990260	920	May M	Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.	BMJ	2011	73
infectious+or+infection	22010913	920	Blanc FX	Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.	The New England journal of medicine	2011	175
infectious+or+infection	22010914	920	Havlir DV	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.	The New England journal of medicine	2011	172
infectious+or+infection	22010915	920	Abdool Karim SS	Integration of antiretroviral therapy with tuberculosis treatment.	The New England journal of medicine	2011	138
infectious+or+infection	22074711	920	Mermin J	Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.	BMJ	2011	54
infectious+or+infection	22101430	920	Waggoner SN	Natural killer cells act as rheostats modulating antiviral T cells.	Nature	2011	142
infectious+or+infection	22160724	920	Aubert RD	Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
infectious+or+infection	22173233	920	Anglaret X	AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.	Clinical infectious diseases 	2012	34
infectious+or+infection	22213804	920	Schulze Zur Wiesch J	Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.	The Journal of experimental medicine	2012	51
infectious+or+infection	22219223	920	Mahnke YD	Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.	Blood	2012	36
infectious+or+infection	22240256	920	Witwer KW	Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.	Retrovirology	2012	49
infectious+or+infection	22253579	920	Ciaranello AL	What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.	PLoS medicine	2012	31
infectious+or+infection	22273267	920	Nglazi MD	Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.	BMC infectious diseases	2012	34
infectious+or+infection	22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
infectious+or+infection	22315957	920	Shah K	A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus.	Journal of the American Geriatrics Society	2012	32
infectious+or+infection	22362849	920	Peter JG	Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.	The European respiratory journal	2012	53
infectious+or+infection	22394050	920	Ferguson L	Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review.	Tropical medicine and international health 	2012	43
infectious+or+infection	22406268	920	Shan L	Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.	Immunity	2012	263
infectious+or+infection	22536323	920	Manabe YC	Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.	PloS one	2012	30
infectious+or+infection	22547421	920	Babiker AG	Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.	Clinical trials	2013	55
infectious+or+infection	22614889	920	Peluso MJ	Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.	AIDS	2012	41
infectious+or+infection	22615543	920	Gibb DM	Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.	PLoS medicine	2012	37
infectious+or+infection	22645358	920	Archin NM	Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.	Proceedings of the National Academy of Sciences of the United States of America	2012	81
infectious+or+infection	22668560	920	Brust JC	Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.	The international journal of tuberculosis and lung disease 	2012	31
infectious+or+infection	22673491	920	Damjanovic D	Immunopathology in influenza virus infection: uncoupling the friend from foe.	Clinical immunology	2012	37
infectious+or+infection	22716976	920	Violari A	Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.	The New England journal of medicine	2012	71
infectious+or+infection	22739389	920	Sunpath H	High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen.	AIDS	2012	32
infectious+or+infection	22784037	920	Baeten JM	Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.	The New England journal of medicine	2012	747
infectious+or+infection	22789644	920	Kim MH	The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi.	Journal of the International AIDS Society	2012	44
infectious+or+infection	22802730	920	Eaton JW	HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.	PLoS medicine	2012	118
infectious+or+infection	22820792	920	Thompson MA	Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.	JAMA	2012	262
infectious+or+infection	22837004	920	Archin NM	Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.	Nature	2012	340
infectious+or+infection	22911011	920	Suthar AB	Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.	PLoS medicine	2012	88
infectious+or+infection	22973181	920	Cornell M	Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.	PLoS medicine	2012	61
infectious+or+infection	22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
infectious+or+infection	22994151	920	Mugglin C	Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.	Tropical medicine and international health 	2012	88
infectious+or+infection	22998068	920	Weber R	Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.	HIV medicine	2013	54
infectious+or+infection	23065532	920	Kalichman SC	Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.	Journal of general internal medicine	2013	34
infectious+or+infection	23066160	920	Chen JY	Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.	The Journal of infectious diseases	2012	71
infectious+or+infection	23148285	920	Nayak JL	CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.	The Journal of infectious diseases	2013	27
infectious+or+infection	23172341	920	Stover J	Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children.	Sexually transmitted infections	2012	45
infectious+or+infection	23206835	920	Jia Z	Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.	Lancet	2013	46
infectious+or+infection	23254153	920	Abraham AG	Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.	Journal of acquired immune deficiency syndromes	2013	36
infectious+or+infection	23292280	920	Yang M	Regulatory B cells in autoimmune diseases.	Cellular and molecular immunology	2013	38
infectious+or+infection	23315315	920	Gale HB	Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts &amp;gt;=300 cells/ŒºL and HIV-1 suppression?	Clinical infectious diseases 	2013	25
infectious+or+infection	23323897	920	SPARTAC Trial Investigators.	Short-course antiretroviral therapy in primary HIV infection.	The New England journal of medicine	2013	70
infectious+or+infection	23323898	920	Le T	Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.	The New England journal of medicine	2013	117
infectious+or+infection	23397353	920	Barron P	Eliminating mother-to-child HIV transmission in South Africa.	Bulletin of the World Health Organization	2013	33
infectious+or+infection	23408629	920	Dahabieh MS	A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.	Journal of virology	2013	25
infectious+or+infection	23418518	920	Luque-Fernandez MA	Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa.	PloS one	2013	37
infectious+or+infection	23435170	920	van Heijst JW	Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.	Nature medicine	2013	47
infectious+or+infection	23446514	920	Centers for Disease Control and Prevention (CDC).	Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.	MMWR. Morbidity and mortality weekly report	2013	81
infectious+or+infection	23459007	920	Eriksson S	Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.	PLoS pathogens	2013	157
infectious+or+infection	23525034	920	Chang CC	Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.	AIDS	2013	27
infectious+or+infection	23532480	920	Witt MD	Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011.	Clinical infectious diseases 	2013	28
infectious+or+infection	23585736	920	Johnson LF	Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.	PLoS medicine	2013	82
infectious+or+infection	23647555	920	Ngarina M	Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.	BMC public health	2013	25
infectious+or+infection	23698063	920	Rodger AJ	Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.	AIDS	2013	77
infectious+or+infection	23698354	920	Moyer VA	Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.	Annals of internal medicine	2013	80
infectious+or+infection	23719296	920	Younan PM	Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.	Blood	2013	31
infectious+or+infection	23732522	920	Pan X	Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.	Cell research	2013	28
infectious+or+infection	23737751	920	Laird GM	Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.	PLoS pathogens	2013	58
infectious+or+infection	23772614	920	Okoye AA	CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.	Immunological reviews	2013	54
infectious+or+infection	23772616	920	Paiardini M	HIV-associated chronic immune activation.	Immunological reviews	2013	47
infectious+or+infection	23780395	920	Hall HI	Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.	JAMA internal medicine	2013	112
infectious+or+infection	23818847	920	Josefsson L	Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.	PLoS pathogens	2013	33
infectious+or+infection	23852127	920	Jain V	Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.	The Journal of infectious diseases	2013	83
infectious+or+infection	23878231	920	Pace CS	Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
infectious+or+infection	23886064	920	Lederman MM	Residual immune dysregulation syndrome in treated HIV infection.	Advances in immunology	2013	68
infectious+or+infection	23921881	920	Mocroft A	The incidence of AIDS-defining illnesses at a current CD4 count ‚â• 200 cells/ŒºL in the post-combination antiretroviral therapy era.	Clinical infectious diseases 	2013	26
infectious+or+infection	23943825	920	Grant PM	Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.	Clinical infectious diseases 	2013	29
infectious+or+infection	24041796	920	Naranbhai V	Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.	The Journal of infectious diseases	2014	21
infectious+or+infection	24064670	920	Turner DL	Lung niches for the generation and maintenance of tissue-resident memory T cells.	Mucosal immunology	2014	58
infectious+or+infection	24121761	920	Gray KM	Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States.	Journal of acquired immune deficiency syndromes	2014	21
infectious+or+infection	24180001	920	P√©rez-Santiago J	Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.	AIDS	2013	28
infectious+or+infection	24198226	920	Lahuerta M	Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.	Clinical infectious diseases 	2014	38
infectious+or+infection	24204277	920	Wibmer CK	Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.	PLoS pathogens	2013	65
infectious+or+infection	24209829	920	Cotton MF	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.	Lancet	2013	50
infectious+or+infection	24218101	920	Rowley CF	Developments in CD4 and viral load monitoring in resource-limited settings.	Clinical infectious diseases 	2014	21
infectious+or+infection	24226057	920	Luetkemeyer AF	Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.	Journal of acquired immune deficiency syndromes	2014	21
infectious+or+infection	24352352	920	Ellis RJ	Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.	Clinical infectious diseases 	2014	23
infectious+or+infection	24382064	920	Bwakura-Dangarembizi M	A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.	The New England journal of medicine	2014	28
infectious+or+infection	24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
infectious+or+infection	24417396	920	Cribbs SK	Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.	AIDS research and human retroviruses	2014	20
infectious+or+infection	24442222	920	Silverberg MJ	Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care.	Journal of acquired immune deficiency syndromes	2014	29
infectious+or+infection	24447595	920	Wynberg E	Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.	Journal of the International AIDS Society	2014	40
infectious+or+infection	24448112	920	Wang S	Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care.	Scientific reports	2014	22
infectious+or+infection	24457342	920	Engsig FN	Long-term mortality in HIV-positive individuals virally suppressed for &amp;gt;3 years with incomplete CD4 recovery.	Clinical infectious diseases 	2014	23
infectious+or+infection	24465532	920	Ngarina M	Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.	PloS one	2014	25
infectious+or+infection	24497929	920	Serrano-Villar S	Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.	PloS one	2014	32
infectious+or+infection	24501199	920	Wertheimer AM	Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans.	Journal of immunology	2014	40
infectious+or+infection	24508219	920	Pfefferbaum A	Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.	Neurobiology of aging	2014	28
infectious+or+infection	24556869	920	May MT	Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.	AIDS	2014	57
infectious+or+infection	24602844	920	Grinsztejn B	Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.	The Lancet. Infectious diseases	2014	101
infectious+or+infection	24608176	920	Sullivan PS	Understanding racial HIV/STI disparities in black and white men who have sex with men: a multilevel approach.	PloS one	2014	54
infectious+or+infection	24675585	920	Nakiyingi L	Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.	Journal of acquired immune deficiency syndromes	2014	31
infectious+or+infection	24687069	920	Post WS	Associations between HIV infection and subclinical coronary atherosclerosis.	Annals of internal medicine	2014	65
infectious+or+infection	24706775	920	Cillo AR	Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	73
infectious+or+infection	24723284	920	Kojic EM	Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.	Clinical infectious diseases 	2014	24
infectious+or+infection	24759213	920	Kumar A	HIV-1 latency in monocytes/macrophages.	Viruses	2014	37
infectious+or+infection	24771333	920	Ingle SM	Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.	Clinical infectious diseases 	2014	25
infectious+or+infection	24941443	920	Blair JM	Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.	MMWR supplements	2014	24
infectious+or+infection	24965451	920	Buzon MJ	Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.	Journal of virology	2014	52
infectious+or+infection	24977376	920	Clouse K	"What they wanted was to give birth; nothing else": barriers to retention in option B+ HIV care among postpartum women in South Africa.	Journal of acquired immune deficiency syndromes	2014	33
infectious+or+infection	25056899	920	Arenaccio C	Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.	Journal of virology	2014	28
infectious+or+infection	25071787	920	Turner DL	Mucosal resident memory CD4 T cells in protection and immunopathology.	Frontiers in immunology	2014	24
infectious+or+infection	25095831	920	Govindasamy D	Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review.	Journal of the International AIDS Society	2014	57
infectious+or+infection	25097264	920	Hill AL	Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1.	Proceedings of the National Academy of Sciences of the United States of America	2014	67
infectious+or+infection	25104632	920	Eaton JW	Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.	The Lancet. Global health	2014	44
infectious+or+infection	25187662	920	Derhovanessian E	Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly.	Journal of immunology	2014	23
infectious+or+infection	25203931	920	Boulle A	Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.	PLoS medicine	2014	29
infectious+or+infection	25253353	920	Soriano-Sarabia N	Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.	Journal of virology	2014	26
infectious+or+infection	25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
infectious+or+infection	25301494	920	Phillips T	Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.	Journal of the International AIDS Society	2014	28
infectious+or+infection	25363779	920	Farh KK	Genetic and epigenetic fine mapping of causal autoimmune disease variants.	Nature	2015	216
infectious+or+infection	25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4‚Å∫ memory T Cells.	Nature communications	2014	27
infectious+or+infection	25426834	920	Ledgerwood JE	Chimpanzee Adenovirus Vector Ebola Vaccine.	The New England journal of medicine	2017	37
infectious+or+infection	25467647	920	Ford N	The future role of CD4 cell count for monitoring antiretroviral therapy.	The Lancet. Infectious diseases	2015	19
infectious+or+infection	25501345	920	Koller M	Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2015	17
infectious+or+infection	25512624	920	Crowell TA	Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.	The Journal of infectious diseases	2015	17
infectious+or+infection	25516189	920	Siedner MJ	Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.	Clinical infectious diseases 	2015	52
infectious+or+infection	25586559	920	Klase Z	Dysbiotic bacteria translocate in progressive SIV infection.	Mucosal immunology	2015	28
infectious+or+infection	25601912	920	Barnabas RV	Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study.	The lancet. HIV	2014	34
infectious+or+infection	25681373	920	Fouts TR	Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
infectious+or+infection	25706092	920	Sulkowski MS	Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.	JAMA	2015	65
infectious+or+infection	25706232	920	Osinusi A	Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.	JAMA	2015	41
infectious+or+infection	25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
infectious+or+infection	25726088	920	Ndiaye BP	Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.	The Lancet. Respiratory medicine	2015	24
infectious+or+infection	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
infectious+or+infection	25882821	920	Friis-M√∏ller N	An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.	European journal of preventive cardiology	2016	14
infectious+or+infection	25967273	920	Wang Z	Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8‚Å∫ T cells.	Nature communications	2015	19
infectious+or+infection	26041300	920	Saunders KO	Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.	Journal of virology	2015	19
infectious+or+infection	26044074	920	Pera A	Immunosenescence: Implications for response to infection and vaccination in older people.	Maturitas	2015	25
infectious+or+infection	26067822	920	Chavez L	HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.	PLoS pathogens	2015	27
infectious+or+infection	26130226	920	Lu W	CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.	Journal of the International AIDS Society	2015	17
infectious+or+infection	26192873	920	INSIGHT START Study Group.	Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.	The New England journal of medicine	2015	340
infectious+or+infection	26193126	920	TEMPRANO ANRS 12136 Study Group.	A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.	The New England journal of medicine	2015	161
infectious+or+infection	26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
infectious+or+infection	26405463	920	Kumar A	Epigenetic control of HIV-1 post integration latency: implications for therapy.	Clinical epigenetics	2015	17
infectious+or+infection	26424550	920	Mussini C	CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.	The lancet. HIV	2015	21
infectious+or+infection	26452565	920	Younas M	Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.	HIV medicine	2016	16
infectious+or+infection	26459351	920	Schulz AR	Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans.	Journal of immunology	2015	17
infectious+or+infection	26633768	920	Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa.	Sustainable HIV treatment in Africa through viral-load-informed differentiated care.	Nature	2015	34
infectious+or+infection	26633769	920	Sharma M	Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.	Nature	2015	38
infectious+or+infection	26725450	920	De Santis O	Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.	The Lancet. Infectious diseases	2016	17
infectious+or+infection	26743582	920	Ondondo B	Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.	Molecular therapy 	2016	13
infectious+or+infection	26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
infectious+or+infection	26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
infectious+or+infection	26962942	920	Monaco CL	Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.	Cell host and microbe	2016	24
infectious+or+infection	27036993	920	Haas AD	Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.	The lancet. HIV	2016	15
infectious+or+infection	27199430	920	Lu CL	Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.	Science	2016	37
infectious+or+infection	27424812	920	Cohen MS	Antiretroviral Therapy for the Prevention of HIV-1 Transmission.	The New England journal of medicine	2016	40
infectious+or+infection	27470028	920	GBD 2015 HIV Collaborators.	Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.	The lancet. HIV	2016	36
infectious+or+infection	27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Œ±4Œ≤7 antibody therapy.	Science	2016	20
infectious+or+infection	28199305	920	Mordm√ºller B	Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.	Nature	2017	10
kidney+or+urine	11431351	920	Nakano O	Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.	Cancer research	2001	107
kidney+or+urine	12411292	920	Gamadia LE	Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.	Blood	2003	108
kidney+or+urine	15327410	920	Szczech LA	The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.	Kidney international	2004	80
kidney+or+urine	16796719	920	Fudaba Y	Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.	American journal of transplantation 	2006	67
kidney+or+urine	17135583	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	CD4+ count-guided interruption of antiretroviral treatment.	The New England journal of medicine	2006	629
kidney+or+urine	17457094	920	Szczech LA	Microalbuminuria in HIV infection.	AIDS	2007	58
kidney+or+urine	18427202	920	Baker JV	CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.	AIDS	2008	106
kidney+or+urine	19838127	920	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	41
kidney+or+urine	20086230	920	Vendrame F	Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.	Diabetes	2010	62
kidney+or+urine	20108382	920	Lawn SD	Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.	AIDS	2009	81
kidney+or+urine	20181972	920	Cain KP	An algorithm for tuberculosis screening and diagnosis in people with HIV.	The New England journal of medicine	2010	87
kidney+or+urine	20352098	920	Dheda K	Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.	PloS one	2010	47
kidney+or+urine	21063582	920	Zhu H	Cost-effective and compact wide-field fluorescent imaging on a cell-phone.	Lab on a chip	2011	62
kidney+or+urine	21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
kidney+or+urine	22362849	920	Peter JG	Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.	The European respiratory journal	2012	53
kidney+or+urine	22824630	920	Kalayjian RC	Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.	AIDS	2012	36
kidney+or+urine	23886064	920	Lederman MM	Residual immune dysregulation syndrome in treated HIV infection.	Advances in immunology	2013	68
kidney+or+urine	24497929	920	Serrano-Villar S	Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.	PloS one	2014	32
kidney+or+urine	24602844	920	Grinsztejn B	Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.	The Lancet. Infectious diseases	2014	101
kidney+or+urine	24675585	920	Nakiyingi L	Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.	Journal of acquired immune deficiency syndromes	2014	31
kidney+or+urine	25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
liver+or+hepatic	10498659	920	Benhamou Y	Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.	Hepatology	1999	208
liver+or+hepatic	12493258	920	Thio CL	HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).	Lancet	2002	211
liver+or+hepatic	14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
liver+or+hepatic	16182404	920	Br√§u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
liver+or+hepatic	16878047	920	Palella FJ Jr	Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.	Journal of acquired immune deficiency syndromes	2006	382
liver+or+hepatic	17135583	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	CD4+ count-guided interruption of antiretroviral treatment.	The New England journal of medicine	2006	629
liver+or+hepatic	18198941	920	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	154
liver+or+hepatic	18427202	920	Baker JV	CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.	AIDS	2008	106
liver+or+hepatic	18435450	920	Engels EA	Cancer risk in people infected with human immunodeficiency virus in the United States.	International journal of cancer	2008	221
liver+or+hepatic	18476292	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.	The Journal of infectious diseases	2008	123
liver+or+hepatic	19571723	920	Marin B	Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.	AIDS	2009	71
liver+or+hepatic	19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
liver+or+hepatic	20380565	920	Antiretroviral Therapy Cohort Collaboration.	Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.	Clinical infectious diseases 	2010	132
liver+or+hepatic	20453631	920	Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group.	Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.	AIDS	2010	121
liver+or+hepatic	21098232	920	Draper SJ	Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.	Journal of immunology	2010	49
liver+or+hepatic	21378535	920	Jani IV	Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing.	AIDS	2011	52
liver+or+hepatic	22547421	920	Babiker AG	Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.	Clinical trials	2013	55
liver+or+hepatic	22998068	920	Weber R	Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.	HIV medicine	2013	54
liver+or+hepatic	23596444	920	Hams E	The schistosoma granuloma: friend or foe?	Frontiers in immunology	2013	33
liver+or+hepatic	23886064	920	Lederman MM	Residual immune dysregulation syndrome in treated HIV infection.	Advances in immunology	2013	68
liver+or+hepatic	24602844	920	Grinsztejn B	Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.	The Lancet. Infectious diseases	2014	101
liver+or+hepatic	24771333	920	Ingle SM	Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.	Clinical infectious diseases 	2014	25
liver+or+hepatic	25706092	920	Sulkowski MS	Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.	JAMA	2015	65
liver+or+hepatic	26452565	920	Younas M	Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.	HIV medicine	2016	16
liver+or+hepatic	26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
pathology	7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
pathology	8095306	920	Connor RI	Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.	Journal of virology	1993	135
pathology	8096068	920	Embretson J	Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.	Nature	1993	306
pathology	8187174	920	York IA	A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.	Cell	1994	164
pathology	9188531	920	Orenstein JM	Macrophages as a source of HIV during opportunistic infections.	Science	1997	152
pathology	10500077	920	Gerlach JT	Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.	Gastroenterology	1999	163
pathology	11009139	920	Whitworth J	Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.	Lancet	2000	106
pathology	11076879	920	Spiller RC	Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.	Gut	2000	188
pathology	11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
pathology	11431351	920	Nakano O	Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.	Cancer research	2001	107
pathology	11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
pathology	12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
pathology	12648460	920	Silvestri G	Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.	Immunity	2003	257
pathology	14557656	920	Guadalupe M	Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.	Journal of virology	2003	336
pathology	14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
pathology	14966528	920	Papagno L	Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.	PLoS biology	2004	124
pathology	15023877	920	Hsue PY	Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.	Circulation	2004	148
pathology	15327410	920	Szczech LA	The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.	Kidney international	2004	80
pathology	15376257	920	Ulrichs T	Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung.	The Journal of pathology	2004	82
pathology	15753209	920	Song Z	Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.	The Journal of experimental medicine	2005	74
pathology	15771578	920	Anderson MS	The NOD mouse: a model of immune dysregulation.	Annual review of immunology	2005	301
pathology	15793563	920	Mattapallil JJ	Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.	Nature	2005	557
pathology	16081852	920	Sutherland JS	Activation of thymic regeneration in mice and humans following androgen blockade.	Journal of immunology	2005	103
pathology	16147978	920	Sylwester AW	Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.	The Journal of experimental medicine	2005	363
pathology	16182404	920	Br√§u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
pathology	16227428	920	Thompson PM	Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.	Proceedings of the National Academy of Sciences of the United States of America	2005	117
pathology	16319344	920	Nicolls MR	Autoimmunity and pulmonary hypertension: a perspective.	The European respiratory journal	2005	79
pathology	16339561	920	Fletcher JM	Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.	Journal of immunology	2005	66
pathology	17035049	920	Chiang MC	3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.	NeuroImage	2007	73
pathology	17090675	920	Levine BL	Gene transfer in humans using a conditionally replicating lentiviral vector.	Proceedings of the National Academy of Sciences of the United States of America	2006	159
pathology	17210718	920	Piersma SJ	High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.	Cancer research	2007	70
pathology	17570691	920	He B	Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.	Immunity	2007	180
pathology	17717638	920	Talmadge JE	Inflammatory cell infiltration of tumors: Jekyll or Hyde.	Cancer metastasis reviews	2007	75
pathology	17916442	920	Boasso A	Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.	Clinical immunology	2008	78
pathology	17986574	920	Koch S	Cytomegalovirus infection: a driving force in human T cell immunosenescence.	Annals of the New York Academy of Sciences	2007	62
pathology	18664624	920	Brenchley JM	Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.	Blood	2008	245
pathology	18802153	920	Dieu-Nosjean MC	Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.	Journal of clinical oncology 	2008	160
pathology	19079157	920	Brenchley JM	HIV infection and the gastrointestinal immune system.	Mucosal immunology	2008	132
pathology	19174797	920	Cremon C	Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.	The American journal of gastroenterology	2009	69
pathology	19383966	920	Hasegawa A	The level of monocyte turnover predicts disease progression in the macaque model of AIDS.	Blood	2009	61
pathology	19647202	920	Carson KR	Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.	The Lancet. Oncology	2009	110
pathology	19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
pathology	20086230	920	Vendrame F	Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.	Diabetes	2010	62
pathology	20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
pathology	20139992	920	Flatz L	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.	Nature medicine	2010	43
pathology	20208541	920	Carter CC	HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.	Nature medicine	2010	112
pathology	20399961	920	Mougiakakos D	Regulatory T cells in cancer.	Advances in cancer research	2010	88
pathology	20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
pathology	20889546	920	Gordon SN	Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.	Journal of immunology	2010	48
pathology	21220772	920	Kaplan RC	T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.	The Journal of infectious diseases	2011	106
pathology	21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
pathology	21398051	920	Finkelstein SE	Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.	International journal of radiation oncology, biology, physics	2012	35
pathology	21471231	920	Ciccone EJ	CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.	Journal of virology	2011	35
pathology	21502920	920	Okulicz JF	Epidemiology and clinical characteristics of elite controllers.	Current opinion in HIV and AIDS	2011	37
pathology	21690475	920	Slingluff CL Jr	Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.	Journal of clinical oncology 	2011	37
pathology	21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
pathology	21737504	920	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	75
pathology	22101430	920	Waggoner SN	Natural killer cells act as rheostats modulating antiviral T cells.	Nature	2011	142
pathology	22174559	920	Marshall NB	Cytotoxic CD4 T cells in antiviral immunity.	Journal of biomedicine and biotechnology	2011	52
pathology	22219223	920	Mahnke YD	Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.	Blood	2012	36
pathology	22291913	920	Lassen KG	A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.	PloS one	2012	42
pathology	22553251	920	Scholler J	Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.	Science translational medicine	2012	143
pathology	22673491	920	Damjanovic D	Immunopathology in influenza virus infection: uncoupling the friend from foe.	Clinical immunology	2012	37
pathology	22745608	920	Cohen CR	Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.	PLoS medicine	2012	81
pathology	22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
pathology	23254153	920	Abraham AG	Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.	Journal of acquired immune deficiency syndromes	2013	36
pathology	23292280	920	Yang M	Regulatory B cells in autoimmune diseases.	Cellular and molecular immunology	2013	38
pathology	23324657	920	Zanni MV	Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.	AIDS	2013	27
pathology	23395677	920	Su LF	Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.	Immunity	2013	113
pathology	23525034	920	Chang CC	Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.	AIDS	2013	27
pathology	23772616	920	Paiardini M	HIV-associated chronic immune activation.	Immunological reviews	2013	47
pathology	23794702	920	Nagaraj S	Reciprocal relationship between myeloid-derived suppressor cells and T cells.	Journal of immunology	2013	38
pathology	23943825	920	Grant PM	Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.	Clinical infectious diseases 	2013	29
pathology	23950730	920	Absher DM	Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations.	PLoS genetics	2013	70
pathology	24041796	920	Naranbhai V	Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.	The Journal of infectious diseases	2014	21
pathology	24045046	920	Jane-Wit D	Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-Œ∫B signaling in endothelial cells.	Circulation	2013	28
pathology	24198226	920	Lahuerta M	Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.	Clinical infectious diseases 	2014	38
pathology	24226057	920	Luetkemeyer AF	Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.	Journal of acquired immune deficiency syndromes	2014	21
pathology	24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
pathology	24417396	920	Cribbs SK	Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.	AIDS research and human retroviruses	2014	20
pathology	24508219	920	Pfefferbaum A	Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.	Neurobiology of aging	2014	28
pathology	25187662	920	Derhovanessian E	Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly.	Journal of immunology	2014	23
pathology	25277040	920	Lueg G	Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.	Neurobiology of aging	2015	20
pathology	25363779	920	Farh KK	Genetic and epigenetic fine mapping of causal autoimmune disease variants.	Nature	2015	216
pathology	25378643	920	Adusumilli PS	Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.	Science translational medicine	2014	62
pathology	25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4‚Å∫ memory T Cells.	Nature communications	2014	27
pathology	25593279	920	Hofmann U	Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction.	Circulation research	2015	20
pathology	25594465	920	Ueno H	Pathophysiology of T follicular helper cells in humans and mice.	Nature immunology	2015	60
pathology	25681373	920	Fouts TR	Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
pathology	25706232	920	Osinusi A	Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.	JAMA	2015	41
pathology	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
pathology	25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4‚Å∫ T cells.	Science	2015	46
pathology	25967273	920	Wang Z	Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8‚Å∫ T cells.	Nature communications	2015	19
pathology	26169416	920	Spivak AM	Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.	Antimicrobial agents and chemotherapy	2015	20
pathology	26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
pathology	26842680	920	Muller L	Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.	Scientific reports	2016	14
pathology	26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
pathology	26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
pathology	26962942	920	Monaco CL	Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.	Cell host and microbe	2016	24
pathology	27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Œ±4Œ≤7 antibody therapy.	Science	2016	20
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	1322294	920	Lewis P	Human immunodeficiency virus infection of cells arrested in the cell cycle.	The EMBO journal	1992	180
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	1361652	920	-	1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.	MMWR. Recommendations and reports 	1992	637
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	7675046	920	Walter EA	Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.	The New England journal of medicine	1995	327
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	7935654	920	Connor EM	Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.	The New England journal of medicine	1994	399
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	9063413	920	Comans-Bitter WM	Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.	The Journal of pediatrics	1997	111
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	10232312	920	Wiktor SZ	Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C√¥te d'Ivoire: a randomised controlled trial.	Lancet	1999	106
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11009139	920	Whitworth J	Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.	Lancet	2000	106
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11117912	920	Greub G	Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.	Lancet	2000	151
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11255423	920	Ickovics JR	Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.	JAMA	2001	232
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11585784	920	Lawn SD	Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.	Clinical microbiology reviews	2001	88
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11794218	920	Gortmaker SL	Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.	The New England journal of medicine	2001	99
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11873003	920	Morgan D	HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?	AIDS	2002	89
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	11953469	920	French N	Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.	AIDS	2002	100
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	12037148	920	Herold KC	Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.	The New England journal of medicine	2002	270
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	12126821	920	Egger M	Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.	Lancet	2002	381
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	14610491	920	Shearer WT	Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.	The Journal of allergy and clinical immunology	2003	152
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	14715541	920	Lugada ES	Population-based hematologic and immunologic reference values for a healthy Ugandan population.	Clinical and diagnostic laboratory immunology	2004	95
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15034567	920	Reece WH	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.	Nature medicine	2004	86
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15247338	920	Lallemant M	Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.	The New England journal of medicine	2004	104
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15247339	920	Jourdain G	Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.	The New England journal of medicine	2004	105
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15464184	920	Newell ML	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.	Lancet	2004	324
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15488218	920	Mermin J	Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.	Lancet	2004	109
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15555666	920	Chintu C	Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.	Lancet	2004	96
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15608532	920	Gebo KA	Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.	Journal of acquired immune deficiency syndromes	2005	118
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15652606	920	Kublin JG	Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.	Lancet	2005	86
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	15832830	920	Mannheimer SB	Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.	AIDS care	2005	79
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16182404	920	Br√§u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16284464	920	Lawn SD	Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.	AIDS	2005	172
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16319381	920	Severe P	Antiretroviral therapy in a thousand patients with AIDS in Haiti.	The New England journal of medicine	2005	99
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16421366	920	Gallant JE	Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.	The New England journal of medicine	2006	193
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16549832	920	Engels EA	Elevated incidence of lung cancer among HIV-infected individuals.	Journal of clinical oncology 	2006	77
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16652060	920	Brahmbhatt H	Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.	Journal of acquired immune deficiency syndromes	2006	71
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16670804	920	Bekker LG	Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.	South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde	2006	66
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16691070	920	Etard JF	Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.	AIDS	2006	124
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	16917006	920	Biggar RJ	Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.	Blood	2006	81
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17367540	920	Reddi A	Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.	BMC pediatrics	2007	67
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17420427	920	Silverberg MJ	Older age and the response to and tolerability of antiretroviral therapy.	Archives of internal medicine	2007	56
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17502729	920	May M	Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.	AIDS	2007	97
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17565153	920	Biggar RJ	AIDS-related cancer and severity of immunosuppression in persons with AIDS.	Journal of the National Cancer Institute	2007	93
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17585291	920	Marin M	Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).	MMWR. Recommendations and reports 	2007	140
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17620755	920	Palombi L	Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.	AIDS	2007	58
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17693883	920	Kamya MR	Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2007	87
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17954540	920	Bolton-Moore C	Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.	JAMA	2007	156
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	17971562	920	Kidder DP	Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS.	American journal of public health	2007	60
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18413766	920	Singh H	Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.	Cancer research	2008	99
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18435450	920	Engels EA	Cancer risk in people infected with human immunodeficiency virus in the United States.	International journal of cancer	2008	221
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18614870	920	Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group.	Response to combination antiretroviral therapy: variation by age.	AIDS	2008	66
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18670668	920	Brinkhof MW	Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.	Bulletin of the World Health Organization	2008	177
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18797643	920	Boulle A	Antiretroviral therapy and early mortality in South Africa.	Bulletin of the World Health Organization	2008	57
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	18981768	920	Nash D	Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.	AIDS	2008	80
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19020325	920	Violari A	Early antiretroviral therapy and mortality among HIV-infected infants.	The New England journal of medicine	2008	388
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19031037	920	Monahan PO	Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya.	Journal of general internal medicine	2009	76
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19056990	920	Mold JE	Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.	Science	2008	207
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19174797	920	Cremon C	Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.	The American journal of gastroenterology	2009	69
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19223334	920	Chi BH	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.	International journal of epidemiology	2009	48
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19282780	920	Nachega JB	Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.	Journal of acquired immune deficiency syndromes	2009	102
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19440326	920	Zolopa A	Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.	PloS one	2009	123
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19552661	920	van Oosterhout JJ	Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.	Tropical medicine and international health 	2009	48
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19569972	920	Kantor R	Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.	Clinical infectious diseases 	2009	57
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19571723	920	Marin B	Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.	AIDS	2009	71
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19616720	920	Wawer MJ	Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.	Lancet	2009	96
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19745753	920	Geng EH	Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.	Journal of acquired immune deficiency syndromes	2010	120
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19770514	920	Sauce D	Evidence of premature immune aging in patients thymectomized during early childhood.	The Journal of clinical investigation	2009	65
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20004464	920	DART Trial Team.	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.	Lancet	2010	126
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20035164	920	Brady MT	Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.	Journal of acquired immune deficiency syndromes	2010	93
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20089951	920	Celum C	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.	The New England journal of medicine	2010	216
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20181972	920	Cain KP	An algorithm for tuberculosis screening and diagnosis in people with HIV.	The New England journal of medicine	2010	87
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20234368	920	Daayana S	Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.	British journal of cancer	2010	57
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20306555	920	Marinda ET	Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2010	43
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20345885	920	Hosseinipour MC	Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.	HIV medicine	2010	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20380565	920	Antiretroviral Therapy Cohort Collaboration.	Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.	Clinical infectious diseases 	2010	132
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20428171	920	Baranzini SE	Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.	Nature	2010	122
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20554983	920	Shapiro RL	Antiretroviral regimens in pregnancy and breast-feeding in Botswana.	The New England journal of medicine	2010	159
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20586958	920	Ekouevi DK	Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.	Tropical medicine and international health 	2010	43
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20588185	920	Fenner L	Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.	Journal of acquired immune deficiency syndromes	2010	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20622679	920	Mtapuri-Zinyowera S	Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.	Journal of acquired immune deficiency syndromes	2010	61
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20638120	920	May M	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.	Lancet	2010	103
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20865049	920	Lugada E	Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya.	PloS one	2010	40
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	20942667	920	Palumbo P	Antiretroviral treatment for children with peripartum nevirapine exposure.	The New England journal of medicine	2010	88
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21107266	920	Davies MA	Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.	Journal of acquired immune deficiency syndromes	2011	39
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21173412	920	Long EF	The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.	Annals of internal medicine	2010	49
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21173675	920	Koyanagi A	Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.	The Pediatric infectious disease journal	2011	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21217181	920	Crump JA	Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.	Clinical infectious diseases 	2011	48
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21378535	920	Jani IV	Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing.	AIDS	2011	52
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21656145	920	Schwartz SR	High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.	AIDS and behavior	2012	46
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21750418	920	Nash D	Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.	AIDS	2011	41
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21779407	920	Bloomfield GS	Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya.	PloS one	2011	37
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21831714	920	Laurent C	Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.	The Lancet. Infectious diseases	2011	38
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21846636	920	Hoft DF	Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.	The Journal of infectious diseases	2011	57
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	21951656	920	Jani IV	Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study.	Lancet	2011	128
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22067665	920	Wandeler G	Outcomes of antiretroviral treatment programs in rural Southern Africa.	Journal of acquired immune deficiency syndromes	2012	35
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22156912	920	Rich ML	Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.	Journal of acquired immune deficiency syndromes	2012	55
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22253579	920	Ciaranello AL	What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.	PLoS medicine	2012	31
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22267016	920	Hall HI	Retention in care of adults and adolescents living with HIV in 13 U.S. areas.	Journal of acquired immune deficiency syndromes	2012	60
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22273267	920	Nglazi MD	Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.	BMC infectious diseases	2012	34
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22394050	920	Ferguson L	Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review.	Tropical medicine and international health 	2012	43
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22531758	920	Fleishman JA	Establishment, retention, and loss to follow-up in outpatient HIV care.	Journal of acquired immune deficiency syndromes	2012	64
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22536323	920	Manabe YC	Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.	PloS one	2012	30
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22615543	920	Gibb DM	Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.	PLoS medicine	2012	37
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22716976	920	Violari A	Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.	The New England journal of medicine	2012	71
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22784037	920	Baeten JM	Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.	The New England journal of medicine	2012	747
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22789644	920	Kim MH	The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi.	Journal of the International AIDS Society	2012	44
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22916256	920	Chamie G	Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda.	PloS one	2012	35
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22944874	920	Althoff KN	U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.	Annals of internal medicine	2012	46
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	22973181	920	Cornell M	Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.	PLoS medicine	2012	61
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23011400	920	Clouse K	Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa.	Journal of acquired immune deficiency syndromes	2013	30
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23065532	920	Kalichman SC	Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.	Journal of general internal medicine	2013	34
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23066160	920	Chen JY	Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.	The Journal of infectious diseases	2012	71
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23075916	920	Dalal W	Home-based HIV testing and counseling in rural and urban Kenyan communities.	Journal of acquired immune deficiency syndromes	2013	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23111762	920	Buchacz K	Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.	Antiviral therapy	2013	32
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23148285	920	Nayak JL	CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.	The Journal of infectious diseases	2013	27
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23172341	920	Stover J	Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children.	Sexually transmitted infections	2012	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23187940	920	Leroy V	Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.	Journal of acquired immune deficiency syndromes	2013	32
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23206835	920	Jia Z	Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.	Lancet	2013	46
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23263176	920	Puthanakit T	Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.	The Pediatric infectious disease journal	2013	38
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23293399	920	Bositis CM	Updates to the World Health Organization's Recommendations for the Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants.	Medical journal of Zambia	2010	40
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23315317	920	Hanna DB	Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.	Clinical infectious diseases 	2013	36
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23324657	920	Zanni MV	Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.	AIDS	2013	27
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23373540	920	Evans D	Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.	AIDS research and human retroviruses	2013	41
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23395677	920	Su LF	Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.	Immunity	2013	113
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23397353	920	Barron P	Eliminating mother-to-child HIV transmission in South Africa.	Bulletin of the World Health Organization	2013	33
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23446514	920	Centers for Disease Control and Prevention (CDC).	Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.	MMWR. Morbidity and mortality weekly report	2013	81
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23473847	920	ARROW Trial team.	Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.	Lancet	2013	47
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23647555	920	Ngarina M	Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.	BMC public health	2013	25
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23658850	920	Cota GF	Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.	PLoS neglected tropical diseases	2013	33
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23669157	920	Udeagu CC	Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care.	AIDS	2013	26
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23698354	920	Moyer VA	Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.	Annals of internal medicine	2013	80
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23741772	920	-			2010	325
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23780395	920	Hall HI	Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.	JAMA internal medicine	2013	112
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23880306	920	Iwuji CC	Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.	Trials	2013	45
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	23939234	920	Weiser SD	Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.	AIDS	2014	31
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24129370	920	Yehia BR	Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.	Journal of acquired immune deficiency syndromes	2014	21
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24184682	920	Lindemans CA	Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.	Blood	2014	23
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24198226	920	Lahuerta M	Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.	Clinical infectious diseases 	2014	38
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24209829	920	Cotton MF	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.	Lancet	2013	50
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24382064	920	Bwakura-Dangarembizi M	A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.	The New England journal of medicine	2014	28
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24419071	920	IeDEA and ART Cohort Collaborations.	Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2014	43
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24447595	920	Wynberg E	Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.	Journal of the International AIDS Society	2014	40
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24465532	920	Ngarina M	Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.	PloS one	2014	25
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24723284	920	Kojic EM	Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.	Clinical infectious diseases 	2014	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24771333	920	Ingle SM	Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.	Clinical infectious diseases 	2014	25
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	24941443	920	Blair JM	Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.	MMWR supplements	2014	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25301494	920	Phillips T	Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.	Journal of the International AIDS Society	2014	28
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25447326	920	Smith JA	Update on ankylosing spondylitis: current concepts in pathogenesis.	Current allergy and asthma reports	2015	16
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25467647	920	Ford N	The future role of CD4 cell count for monitoring antiretroviral therapy.	The Lancet. Infectious diseases	2015	19
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25501345	920	Koller M	Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.	Journal of acquired immune deficiency syndromes	2015	17
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25512624	920	Crowell TA	Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.	The Journal of infectious diseases	2015	17
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25516189	920	Siedner MJ	Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.	Clinical infectious diseases 	2015	52
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25726088	920	Ndiaye BP	Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.	The Lancet. Respiratory medicine	2015	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4‚Å∫ T cells.	Science	2015	46
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	26193635	920	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	20
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	26348035	920	Choko AT	Uptake, Accuracy, Safety, and Linkage into Care over Two Years of Promoting Annual Self-Testing for HIV in Blantyre, Malawi: A Community-Based Prospective Study.	PLoS medicine	2015	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	26633768	920	Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa.	Sustainable HIV treatment in Africa through viral-load-informed differentiated care.	Nature	2015	34
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	26657141	920	Thome JJ	Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.	Nature medicine	2016	24
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	27019159	920	Bakulski KM	DNA methylation of cord blood cell types: Applications for mixed cell birth studies.	Epigenetics	2016	23
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	27036993	920	Haas AD	Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.	The lancet. HIV	2016	15
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	27222480	920	Krejcik J	Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.	Blood	2016	17
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	27470028	920	GBD 2015 HIV Collaborators.	Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.	The lancet. HIV	2016	36
pediatric+or+newborn+or+infant+or+toddler+or+child+or+adolescent	28199305	920	Mordm√ºller B	Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.	Nature	2017	10
plasma+or+serum	2395859	920	Daar ES	High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.	Proceedings of the National Academy of Sciences of the United States of America	1990	162
plasma+or+serum	3107838	920	Stein BS	pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.	Cell	1987	235
plasma+or+serum	3299090	920	Richman DD	The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	195
plasma+or+serum	9217758	920	Cohen MS	Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.	Lancet	1997	181
plasma+or+serum	9287227	920	Hammer SM	A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.	The New England journal of medicine	1997	394
plasma+or+serum	9360926	920	Wong JK	Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.	Science	1997	528
plasma+or+serum	9371822	920	Chun TW	Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	1997	463
plasma+or+serum	9420212	920	Matano T	Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.	Journal of virology	1998	185
plasma+or+serum	10196297	920	Mascola JR	Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.	Journal of virology	1999	336
plasma+or+serum	10341272	920	Zhang L	Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.	The New England journal of medicine	1999	195
plasma+or+serum	10419445	920	Lucas GM	Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.	Annals of internal medicine	1999	141
plasma+or+serum	10607709	920	Hazenberg MD	T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).	Blood	2000	129
plasma+or+serum	10837072	920	Pierson T	Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.	Annual review of immunology	2000	162
plasma+or+serum	11192870	920	Marzolini C	Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.	AIDS	2001	150
plasma+or+serum	11434728	920	Murphy EL	Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.	Annals of internal medicine	2001	121
plasma+or+serum	11711588	920	Betts MR	Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.	Journal of virology	2001	251
plasma+or+serum	11722271	920	Hogg RS	Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.	JAMA	2001	162
plasma+or+serum	11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
plasma+or+serum	11752161	920	Zhu T	Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.	Journal of virology	2002	115
plasma+or+serum	11917238	920	Giorgi JV	Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.	Journal of acquired immune deficiency syndromes	2002	96
plasma+or+serum	11953469	920	French N	Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.	AIDS	2002	100
plasma+or+serum	12131186	920	Ling B	SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.	AIDS	2002	89
plasma+or+serum	12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
plasma+or+serum	12637625	920	Lalezari JP	Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.	The New England journal of medicine	2003	148
plasma+or+serum	12693883	920	Palella FJ Jr	Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.	Annals of internal medicine	2003	109
plasma+or+serum	12721933	920	Hunt PW	T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.	The Journal of infectious diseases	2003	296
plasma+or+serum	12773645	920	Lazzarin A	Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.	The New England journal of medicine	2003	102
plasma+or+serum	14557216	920	Kaufmann GR	CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.	Archives of internal medicine	2003	85
plasma+or+serum	14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
plasma+or+serum	15117761	920	Deeks SG	Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.	Blood	2004	289
plasma+or+serum	15210746	920	Matano T	Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.	The Journal of experimental medicine	2004	89
plasma+or+serum	15247339	920	Jourdain G	Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.	The New England journal of medicine	2004	105
plasma+or+serum	15280419	920	Kinter AL	CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.	The Journal of experimental medicine	2004	159
plasma+or+serum	15577629	920	Buchacz K	Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections.	AIDS	2004	92
plasma+or+serum	15840880	920	Strickler HD	Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.	Journal of the National Cancer Institute	2005	162
plasma+or+serum	16182404	920	Br√§u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
plasma+or+serum	16631548	920	Battegay M	Immunological recovery and antiretroviral therapy in HIV-1 infection.	The Lancet. Infectious diseases	2006	61
plasma+or+serum	16631912	920	Ferradini L	Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.	Lancet	2006	191
plasma+or+serum	16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
plasma+or+serum	16905788	920	Hammer SM	Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.	JAMA	2006	160
plasma+or+serum	17035049	920	Chiang MC	3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.	NeuroImage	2007	73
plasma+or+serum	17135583	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	CD4+ count-guided interruption of antiretroviral treatment.	The New England journal of medicine	2006	629
plasma+or+serum	17258731	920	von Hahn T	Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.	Gastroenterology	2007	144
plasma+or+serum	17357054	920	Baeten JM	HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.	The Journal of infectious diseases	2007	81
plasma+or+serum	17728240	920	Chen P	Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.	Journal of virology	2007	172
plasma+or+serum	18171295	920	Hunt PW	Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.	The Journal of infectious diseases	2008	248
plasma+or+serum	18195140	920	Letendre S	Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.	Archives of neurology	2008	229
plasma+or+serum	18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
plasma+or+serum	18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
plasma+or+serum	18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
plasma+or+serum	18525258	920	Archin NM	Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.	AIDS	2008	84
plasma+or+serum	18677028	920	Hammer SM	Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.	JAMA	2008	294
plasma+or+serum	18981777	920	Lima VD	Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.	AIDS	2008	54
plasma+or+serum	19123865	920	Robbins GK	Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.	Clinical infectious diseases 	2009	73
plasma+or+serum	19193107	920	Kelley CF	Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.	Clinical infectious diseases 	2009	99
plasma+or+serum	19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
plasma+or+serum	19440326	920	Zolopa A	Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.	PloS one	2009	123
plasma+or+serum	19444075	920	Grabar S	Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.	AIDS	2009	50
plasma+or+serum	19687491	920	Zhang F	Five-year outcomes of the China National Free Antiretroviral Treatment Program.	Annals of internal medicine	2009	93
plasma+or+serum	19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
plasma+or+serum	19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
plasma+or+serum	19838127	920	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	41
plasma+or+serum	19911963	920	Hoffmann CJ	Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.	Clinical infectious diseases 	2009	53
plasma+or+serum	20089951	920	Celum C	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.	The New England journal of medicine	2010	216
plasma+or+serum	20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
plasma+or+serum	20153888	920	Lingappa JR	Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.	Lancet	2010	69
plasma+or+serum	20170371	920	Euler Z	Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.	The Journal of infectious diseases	2010	66
plasma+or+serum	20306555	920	Marinda ET	Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2010	43
plasma+or+serum	20457954	920	Ellis RJ	Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.	Archives of neurology	2010	84
plasma+or+serum	20505494	920	Ford ES	Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.	AIDS	2010	73
plasma+or+serum	20516524	920	Letendre SL	Neurologic complications of HIV disease and their treatment.	Topics in HIV medicine 	2010	84
plasma+or+serum	20537376	920	Donnell D	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.	Lancet	2010	343
plasma+or+serum	20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
plasma+or+serum	20597693	920	Meya DB	Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count &amp;lt; or = 100 cells/microL who start HIV therapy in resource-limited settings.	Clinical infectious diseases 	2010	78
plasma+or+serum	20697368	920	Cutler C	Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.	Bone marrow transplantation	2011	38
plasma+or+serum	20711481	920	Gandhi RT	The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.	PLoS medicine	2010	119
plasma+or+serum	20739646	920	Vivithanaporn P	Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.	Neurology	2010	69
plasma+or+serum	20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
plasma+or+serum	21135382	920	Heaton RK	HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.	Neurology	2010	609
plasma+or+serum	21217181	920	Crump JA	Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.	Clinical infectious diseases 	2011	48
plasma+or+serum	21249232	920	Mikell I	Characteristics of the earliest cross-neutralizing antibody response to HIV-1.	PLoS pathogens	2011	135
plasma+or+serum	21325137	920	Ganesan A	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.	The Journal of infectious diseases	2011	48
plasma+or+serum	21367910	920	Anderson JA	Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.	Journal of virology	2011	38
plasma+or+serum	21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
plasma+or+serum	21471244	920	Xing S	Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.	Journal of virology	2011	79
plasma+or+serum	21494598	920	Merlini E	Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.	PloS one	2011	42
plasma+or+serum	21502083	920	Hunt PW	Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.	The Journal of infectious diseases	2011	98
plasma+or+serum	21502920	920	Okulicz JF	Epidemiology and clinical characteristics of elite controllers.	Current opinion in HIV and AIDS	2011	37
plasma+or+serum	21507924	920	Gandhi M	Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.	Clinical infectious diseases 	2011	41
plasma+or+serum	21543722	920	Letvin NL	Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.	Science translational medicine	2011	109
plasma+or+serum	21628667	920	Chun TW	Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.	The Journal of infectious diseases	2011	58
plasma+or+serum	21690402	920	Josefsson L	Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.	Proceedings of the National Academy of Sciences of the United States of America	2011	75
plasma+or+serum	21782230	920	Dixon AE	Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.	The Journal of allergy and clinical immunology	2011	66
plasma+or+serum	21802367	920	Hamers RL	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.	The Lancet. Infectious diseases	2011	99
plasma+or+serum	21881481	920	Hunt PW	Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.	AIDS	2011	87
plasma+or+serum	21890751	920	Mugavero MJ	Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.	Clinical infectious diseases 	2011	41
plasma+or+serum	22240256	920	Witwer KW	Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.	Retrovirology	2012	49
plasma+or+serum	22275402	920	Durand CM	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.	The Journal of infectious diseases	2012	40
plasma+or+serum	22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
plasma+or+serum	22448150	920	Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.	CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.	PLoS medicine	2012	38
plasma+or+serum	22614889	920	Peluso MJ	Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.	AIDS	2012	41
plasma+or+serum	22716976	920	Violari A	Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.	The New England journal of medicine	2012	71
plasma+or+serum	22745608	920	Cohen CR	Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.	PLoS medicine	2012	81
plasma+or+serum	22824630	920	Kalayjian RC	Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.	AIDS	2012	36
plasma+or+serum	22944874	920	Althoff KN	U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.	Annals of internal medicine	2012	46
plasma+or+serum	22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
plasma+or+serum	23206835	920	Jia Z	Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.	Lancet	2013	46
plasma+or+serum	23283367	920	Garc√≠a F	A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.	Science translational medicine	2013	46
plasma+or+serum	23323898	920	Le T	Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.	The New England journal of medicine	2013	117
plasma+or+serum	23698063	920	Rodger AJ	Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.	AIDS	2013	77
plasma+or+serum	23818847	920	Josefsson L	Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.	PLoS pathogens	2013	33
plasma+or+serum	24184682	920	Lindemans CA	Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.	Blood	2014	23
plasma+or+serum	24185941	920	Krishnan S	Evidence for innate immune system activation in HIV type 1-infected elite controllers.	The Journal of infectious diseases	2014	40
plasma+or+serum	24204277	920	Wibmer CK	Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.	PLoS pathogens	2013	65
plasma+or+serum	24352352	920	Ellis RJ	Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.	Clinical infectious diseases 	2014	23
plasma+or+serum	24620025	920	Archin NM	HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.	The Journal of infectious diseases	2014	75
plasma+or+serum	25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
plasma+or+serum	25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
plasma+or+serum	25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4‚Å∫ memory T Cells.	Nature communications	2014	27
plasma+or+serum	25594465	920	Ueno H	Pathophysiology of T follicular helper cells in humans and mice.	Nature immunology	2015	60
plasma+or+serum	25706092	920	Sulkowski MS	Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.	JAMA	2015	65
plasma+or+serum	25706232	920	Osinusi A	Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.	JAMA	2015	41
plasma+or+serum	25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
plasma+or+serum	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
plasma+or+serum	26130226	920	Lu W	CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.	Journal of the International AIDS Society	2015	17
plasma+or+serum	26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
plasma+or+serum	26414912	920	Hendrix CW	Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).	AIDS research and human retroviruses	2016	17
plasma+or+serum	26633768	920	Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa.	Sustainable HIV treatment in Africa through viral-load-informed differentiated care.	Nature	2015	34
plasma+or+serum	26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
plasma+or+serum	27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Œ±4Œ≤7 antibody therapy.	Science	2016	20
rheumatic	24786080	920	Raj T	Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.	Science	2014	90
stem+cells	10364556	920	Siegal FP	The nature of the principal type 1 interferon-producing cells in human blood.	Science	1999	466
stem+cells	16282341	920	Berger C	Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.	Blood	2006	87
stem+cells	18198941	920	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	154
stem+cells	18413766	920	Singh H	Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.	Cancer research	2008	99
stem+cells	18728188	920	Swijnenburg RJ	Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.	Proceedings of the National Academy of Sciences of the United States of America	2008	92
stem+cells	20208541	920	Carter CC	HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.	Nature medicine	2010	112
stem+cells	21148519	920	Peggs KS	Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.	Clinical infectious diseases 	2011	43
stem+cells	22275402	920	Durand CM	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.	The Journal of infectious diseases	2012	40
stem+cells	22553251	920	Scholler J	Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.	Science translational medicine	2012	143
stem+cells	22999944	920	Eisele E	Redefining the viral reservoirs that prevent HIV-1 eradication.	Immunity	2012	116
stem+cells	23719296	920	Younan PM	Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.	Blood	2013	31
stem+cells	24041796	920	Naranbhai V	Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.	The Journal of infectious diseases	2014	21
stem+cells	24965451	920	Buzon MJ	Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.	Journal of virology	2014	52
stem+cells	25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
stem+cells	25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
stem+cells	25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4‚Å∫ memory T Cells.	Nature communications	2014	27
stem+cells	25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
stem+cells	25888703	920	Goronzy JJ	Naive T cell maintenance and function in human aging.	Journal of immunology	2015	22
toxicology+or+toxic+or+toxin	3299090	920	Richman DD	The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	195
toxicology+or+toxic+or+toxin	7675046	920	Walter EA	Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.	The New England journal of medicine	1995	327
toxicology+or+toxic+or+toxin	7935654	920	Connor EM	Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.	The New England journal of medicine	1994	399
toxicology+or+toxic+or+toxin	12491162	920	Sacktor N	The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.	Journal of neurovirology	2002	109
toxicology+or+toxic+or+toxin	16319381	920	Severe P	Antiretroviral therapy in a thousand patients with AIDS in Haiti.	The New England journal of medicine	2005	99
toxicology+or+toxic+or+toxin	18382686	920	Funderburg N	Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.	PloS one	2008	60
toxicology+or+toxic+or+toxin	18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
toxicology+or+toxic+or+toxin	19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
toxicology+or+toxic+or+toxin	20004464	920	DART Trial Team.	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.	Lancet	2010	126
toxicology+or+toxic+or+toxin	20108382	920	Lawn SD	Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.	AIDS	2009	81
toxicology+or+toxic+or+toxin	20371685	920	Grossman SA	Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.	Clinical cancer research 	2010	129
toxicology+or+toxic+or+toxin	21471244	920	Xing S	Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.	Journal of virology	2011	79
toxicology+or+toxic+or+toxin	21690475	920	Slingluff CL Jr	Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.	Journal of clinical oncology 	2011	37
toxicology+or+toxic+or+toxin	21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
toxicology+or+toxic+or+toxin	21831714	920	Laurent C	Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.	The Lancet. Infectious diseases	2011	38
toxicology+or+toxic+or+toxin	22362849	920	Peter JG	Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.	The European respiratory journal	2012	53
toxicology+or+toxic+or+toxin	22820792	920	Thompson MA	Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.	JAMA	2012	262
toxicology+or+toxic+or+toxin	23065532	920	Kalichman SC	Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.	Journal of general internal medicine	2013	34
toxicology+or+toxic+or+toxin	24185941	920	Krishnan S	Evidence for innate immune system activation in HIV type 1-infected elite controllers.	The Journal of infectious diseases	2014	40
toxicology+or+toxic+or+toxin	24675585	920	Nakiyingi L	Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.	Journal of acquired immune deficiency syndromes	2014	31
